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ABSTRACT OF THESIS 
The total synthesis of the 3-polyenoyltetramic acid antibiotic altamycin A has been attempted via a 
novel method of preparing enantiomerically pure tetramic acids. 
Thus two target fragments were identified: (a) the tetramic acid and (b) the polyenal fragment. The 
chirality present in the latter was introduced (enantioselectively) through the catalytic Sharpless 
epoxidation of an isomerically pure allylic alcohol. This epoxide was then elaborated, using Wittig 
technology, into the aforementioned polyenal unit. 
The chiral tetramic acid was readily available through reaction of an ester enolate with an 
oxazolidine-2,5-dione of desired stereochemistry. 
The coupling of these fragments was studied - several methods being tried then evaluated according 
to their expediency. 
This approach to altamycin A is sufficiently flexible to allow the preparation of other members of 
this interesting class of naturally occurring compounds. 
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1. INTRODUCTION 
Altamycin A [1]1, cx-lipomycin [2]2 and oleficin [3]3 are members of a growing class of naturally 




Altamycin A 	1 
a - Lipomycin 2 
Oleficin 	3 
The total synthesis of these molecules presents a great challenge to the organic chemist as there are 
three chiral centres and an all-trans polyene chain to be constructed in the correct manner. Thus a 
synthesis must be flexible in two ways; (a) to enable polyenes of varying length to be made and (b) 
to allow synthesis of all four diastereoisomers. The fulfilment of these requirements will allow the 
determination of the absolute stereochemistry of the natural products and provide material for the 
detailed study of the biological action of these systems. 
A discussion of the structure of the tetrarnic acid heterocycle and the naturally occurring tetramic 
acids is presented to show the importance of this class of compounds in nature. A brief review of 
previous synthetic strategies directed towards the construction of tetramic acids is included to give 
an indication of their strengths and weaknesses and foster an appreciation of the difficulties 
encountered in this area. 
2 
1.1 THE STRUCTURE OF TETRAMIC ACIDS 
Tetramic acids have been represented as derivatives of the enolic 4-hydroxy-3-pyrroline-2-one 
tautomer [4] of the corresponding pyrrolidine-2,4-dione keto form [5].  This was done by analogy 
with teironic acid [6],  on the assumption that such derivatives would show similar physical and 
chemical properties. Tetronic acid was first synthesised in 1896 and is strongly acidic 
(pKa=3.765) in aqueous solution. The solid-state infrared spectrum is consistent with the enolic 
structure [6]6  showing absorptions at 1690(C=O) and 1635(C=C) cm whilst the ultraviolet 
spectrum in aqueous ethanol showed absorptions at ? max 223 nm and 248 nm due to the enol [6] 
and the enolate [7], the proportion of each being pH dependent7 (Scheme 1). 
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SCHEME 1 
Tetramic acid [5] was surprisingly not synthesised until 1972 (earlier attempts resulted in the 
formation of the isomeric 2-iminotetronic acid [819"°),and  is a much weaker acid than tclronic acid 
with pKa=6.4 in aqueous solution8. Consequently tetramic acid [5] is not highly enolised and exists 
mainly in the 2,4-diketo form (Scheme I). The solid state i.r. spectrum shows absorptions at 3230 
(NH stretch), 1696 (lactam C=O), 1670 (NH bend) and 1782 cm which was assigned to the C-4 
3 
ketone carbonyl group. This band was also observed in the solution i.r. spectrum so it was 
concluded that the lactam group participates in hydrogen bonding in the solid state. Ultraviolet 
spectroscopy showed a single absorption at ? max 260 nm due to the enolate species [9] with the 
intensity being strongly pH dependent. This meant that the ionised form [9] exists predominately in 
equilibrium with the 2,4-diketo form [5] in aqueous solution, with the enolic tautomer [4] being 
absent (Scheme 2). 






Tetramic acids bearing acyl or alkoxycarbonyl substituents at the 3-position are found to have much 
increased acidity. The former [10] have pKa values in the range 3.0- 3511,12 whilst the latter [11] 
are in the range 2.3 - 2.5. Proton n.m.r. spectra indicate the complete enolisation of these systems 
although the presence of several tautomeric forms complicates the spectra. The tautomerism of 3-
acylietramic acids was explained by a mechanism which involves two sets of rapidly interchanging 
internal tautomers [12a ± 12b] and [12c 	12d], where each set arises from proton transfer along 
the intramolecular hydrogen bond, together with two pairs of slowly interconverting external 
tautomers [12a, b] 	[12c, d], arising from the rotation of the acyl side chain (Scheme 3)13• 
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SCHEME 3 
The internal tautomerisation of these derivatives occurs too rapidly to be detected on the time scale 
of an n.m.r. experiment; the external tautomerism, however, is of a rate which can be measured by 
n.rn.r. methods and this has provided an interesting insight into this dynamic equilibrium. The ratios 
5 
of the external tautomers have been determined by Steyn and Wessels 14,15(a)  in a comprehensive 
analysis of the 1H and 13C n.m.r. characteristics of 3-acylteiramic acids of type [12c, d] with the 
observed chemical shifts and coupling constants representing the weighted averages of the 
corresponding values of the internal tautomers [12a 	b] and [12c # d]. 
Steyn and Wessels 14,15(a)  found 13C n.m.r. spectroscopy more useful for the study of the 
tautomerisation in tetramic acids as the chemical shift of the 13C nucleus depends on the 
hybridisation of the carbon atom and is hardly affected by the anisotropy of neighbouring functional 
groups. The carbon resonances were assigned using off-resonance proton decoupled and single 
frequency nuclear Overhauser effect (n.O.e.) 13C n.m.r. spectra and they were then able to deduce 
the main tautomers with the help of some earlier work by Strothers and Lauterbur16 which showed 
that enolic carbon atoms resonate at lower frequency than the corresponding keto carbons, and that 
hydrogen bonded carbonyl carbon atoms resonate at higher frequency than a corresponding free 
carbonyl. The enolic forms [12b] and [12d] (Scheme 3) were deduced to be the main tautomers 
from the predominance of the lower frequency C-6 enolic carbon atom resonance. The 
predominance of the higher frequency C-2 hydrogen bonded carbonyl signal led to the conclusion 
that the exo-enol [12d] is the main tautomeric form. 
The approximate ratios of each of the tautomers was also calculated in the same study. This gave 
the ratio of individual tautomers [12a]:[12b]:[12c]:[12d] for simple 3-acyltetramic acids as 
5:15:0:8015(a) and although this contradicted the results of Yamaguchi 15(b),  based on 'H n.m.r. 
work, the conclusions of Steyn and WesselslS(a)  are unequivocally substantiated by the X-ray 
crystallographic structure determination of tetramic acid [13], found to exist in the exo-endo enolic 
form (Scheme 4). 
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1.2 THE NATURALLY OCCURRING TETRAMIC ACIDS 
The literature covering the isolation, characterisation, structural assignment and chemical synthesis 
of naturally occurring tetramic acids has been reviewed, at some length, recently 17,18,19 In view 
of this it is intended that the following review be a concise summary of the previous articles that has 
been updated so as to include the most recent literature. 
1.2.1 THE 3-ACYLTETRAMIC ACIDS 
Pyrrolidine-2,4-diones bearing a 3-acyl substituent are the most commonly found tetramic acids in 
nature. Tenuazonic acid [14] is the simplest 3-acyltetramic acid and was isolated in 1957 by 
Stickings group20 from the culture filtrate of Alternaria lennius auct. Degradation by acidic 
hydrolysis gave L-isoleucine, establishing the absolute stereochemistry at C-5 and C-8, and its 
eIyi 




Tenuazonic acid exhibits a low level of antibacterial activity22, and inhibits a number of viruses at 
high dose levels including Measles (Enders), Vaccinia and Herpes Simplex (HF)23. Tenuazonic 
acid also shows the ability to inhibit human adenocarcinoma growing in the cinbryonatcd egg24 
'A 
with the mode of action proposed to involve the inhibition of incorporation of amino acids into 
proteins2. Much attention has been given to tenuazonic acid because of the broad spectrum of 
biological activity it displays but it has been of limited value due to its extreme toxicity 25,27• 
Studies into the biosynthesis of tenuazonic acid [14] led to the isolation of radioactive N-
acetoacetyl-L-isoleucine [16] from feeding experiments using [1-14C] labelled acetate and it was 
concluded 28,29,30  that the biosynthetic pathway involved cyclisation of an N-acetoacetyl-L-
isoleucine [16] species rather than cyclisation of N-acetyl-L-isoleucine to deacetyltenuazonic acid 
[17] followed by acylation at C-3 (Scheme 6). 
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Kohl and his colleagues3' isolated the antibiotic magnesidin from Psueudomonas magnesiorubia sp. 
nov. as a 1:1 mixture of the covalent magnesium chelates of 1-acetyl-5 -ethyl idene-3-
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SCHEME 7 
The structures of [18] and [19] were determined by chemical degradation31  and magnesidin was 
shown to inhibit various Gram-positive bacteria in very low concentrations without the toxicity 
found in tenuazonic acid32. In fact, since tenuazonic acid has also been isolated as a mixture of 
magnesium and calcium complexes33'34 and previous isolation techniques20 involved an 
acidification step, it has been suggested that the natural form of this and related compounds may 
well be as covalent metal chelates. 
The structurally interesting mycotoxin, a-cyclopiazonic acid [20], is produced by the fungus 
Penicillium cyclopium Westling; Holzapfe135 used chemical and spectroscopic evidence to assign 
the structure and relative stereochemistry. Biosynthetic studies 36,37,38  identified the incorporation 







Ikarugamycin [21] was isolated from the culture broth of Streptomyces phaeochromogens var. 
ikarugamycin Sakai39 and shows strong specific antiprotozoal activity, in vitro antiamoebic activity 
as well as activity against some Gram-positive bacteria. It contains some very unusual structural 
features; an enoyltetramic acid which is part of a macrocyclic lactam and the trans-anti-cis-
decahydro-as-indacene ring-system. The structure and absolute stereochemistry of ikarugamycin 
[21] were determined by an elegant structure proof carried out by Ito and Hirata40. The related 
antibiotic capsimycin41  [22] is the only other known example of a tetramic acid with this interesting 
tricyclic system. The structure was determined by comparison of spectral data with that of 









The structure of malonomycin [23], an antiprotozoal compound isolated from Streptomyces rimosus 
var. paromomycinus42, was elucidated by Batclaan and co-workers43'44 in 1972. The unique 
aminomalonic acid moiety that forms part of the 3-acyl sidechain of the tetramic acid was found to 
be essential for the biological activity of the compound. Decarboxylation by brief reflux in water 
gave the inactive derivative [24IJ 	(Scheme 10). Biosynthetic studies on malonomycin have 




















1.2.2 THE 3-POLYENOYLTETRAMIC ACIDS 
The title compounds form a sub-group of 3-acyltetramic acids which exhibit a range of biological 
activity including antiviral, antibiotic and antitumoural activity. Structural features common to 
members of this sub-group are a tetramic acid nucleus with a polyenoyl substituent at C-3; there is, 
however, much diversity in the functionalisation of the polyene chain and the substitution at N-i and 
C-5 of the heterocyclic ring. 
The first of the dienoyl tetramic acids to be isolated was streptolydigin [25]46 which has a fairly 
complex set of substituents; a methyl propionamide at C-5, a 2,3,6-trideoxyaldohexose at N-i and 
2,9-dioxabicyclo[3,3,l] nonane subunit. The structure was assigned by study of the chromophore47 
along with synthetic work on streptolic acid48 [26], which is the periodate oxidation product of 
streptolydigin [25]. The stereochemistry was not determined. Synthesis established the hexose 
component as 2,3,6-trideoxy-L-threo-aldohexose49 (Scheme ii). 
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Mayer isolated50 tirandamycin [27] from Streptomyces tirandis var. tirandis in 1971 and the 
compound was found to have similar biological properties to streptolydigin [25]. In common with 
12 
streptolydigin, tirandamycin A has attracted considerable interest due to its potent inhibition of 
bacterial DNA-directed RNA polymerase5' and selective inhibition of terminal deoxynucleotidyl 
transferase from leukemic cells52. The structure was assigned by comparison of the spectral 
properties of streptolydigin and tirandamycin A [27]. X-ray crystal structure studies on the p-
bromophenacyl ester of tirandamycic acid [28], which was obtained by periodate oxidation of 
[27], allowed the absolute stereochemistry of tirandamycin A to be determined (Scheme 12). 
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Tirandamycic acid [28] and streptolic acid [26] were both converted to streptolol [29] (Scheme 13) 
thus proving that the overall stereochemistry of streptolic and tirandamycic acids was identical; this 
enabled the structure [25] to be assigned unambiguously to streptolydigin54 
SCHEME 13, reagents: (a) hydrazine, AcOH; (b) lithal, ether. 
14 
Two closely related 3-dienoyltetramic acids Bu2313A [31] and Bu2313B [32] have been isolated55  
from an unidentified oligosporic strain of an actinornycete. Both are broad spectrum antibiotics, 
effective against Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic 
bacteria such as Streptococci55. Their structures were also determined55 by X-ray crystal structure 
work on the respective p-bromophenacyl esters of the two periodate oxidation products [33] and 
[34] (Scheme 14). 
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A structurally unique hybrid of the streptolydigin-tirandamycin families of antibiotics, 
tirandalydigin [35], has recently been isolated56 from the fermentation beers of Streptomyces sp. 
AB-1006A-9. This anti-anaerobic antibiotic57 has been assigned structure [35] on the basis of u.v., 
n.m.r. and mass spectrometric data, although there is no firm evidence to prove the absolute 
stereochemistry. The configuration shown for structure [35] (Scheme 15) is assumed because of 





Naturally occurring tetramic acids with a polyene chromophore include the orange-red pigment of 
Penicillium islandicum Sopp., crythroskyrine [36]58.  Erythroskyrine was shown to contain the 3-
pentaenoyl substituent by spectral evidence and the absolute configuration at C-5 was determined as 
(S) by degradation to L-(+)-N-mcthylvaline, however the question of the stereochemistry in the 
bicyclic ring system was not addressed58 (Scheme 16). 
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Feeding studies59, using [1-14C] or [2-14C] labelled sodium acetate and [1 4C] or 2-14C] diethyl 
malonate, showed that C-l' to C-16' were derived from malonate whilst C-iT and C-18' were 
acetate derived. The amino acid constituent in the tetramic acid was shown to be from L-valine [37] 
by uptake of 14C-carboxyl labelled material into erythroskyrine. The biosynthetic origin of the N-
methyl group as well as C-2 and C-3 of the tetramic acid could not be determined due to 
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Fuligorubin A [38] was isolated from the slime mould Fuligo septica (L.).Wiggers by Steglich60, 
who showed that it was responsible for the yellow appearance of the slime mould because of the 
polyenoyltetramic acid chromophore. The structure of fuligorubin A [38] was deduced from 
spectral data whilst studies of the chiroptic properties of decahydrofuligorubin A [39] led to the 













A 3-polyenoyltet.ramic acid with the same chromophore as erythroskyrine [36] was isolated from 
Streptomyces aureofaciens in 1972 by Zeeck61  and subsequently assigned structure [2]62. 
Methanolysis of c-lipomycin [2], using a trace of acid, afforded cs-lipomycin methyl ester [40] 
and methyl-f3—D-digitoxoside [41]. The stereochemical identity of the sugar was confirmed by 
comparison with an authentic sample. Chromatography of a-lipomycin on silica gel (impregnated 
with oxalic acid) gave the aglycone 3-lipomycin [42] which was found to absorb five equivalents of 
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SCHEME 19 
The decadehydro derivative [43] was shown to have similar spectroscopic properties to tenuazonic 
acid [14] whilst c- and -lipomycin contained the same chromophore as erythroskyrine [36]. The 
absolute configuration at C-5 of the teiramic acid was determined to be (S) by degradation 
(ozonolysis, followed by acidic hydrolysis) of -lipomycin [42] which gave L-N-mcthylglutamic 
acid [44]. Further chemical studies were carried out to determine the position of the isopropyl group 
HQC 
19 
but the stereochemistry (both relative and absolute) of C-12' and C-13' could not be assigned 
(Scheme 20) 62 
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a-Lipomycin [2] and J3-lipomycin [42] both exhibited selective inhibition of the growth of Gram-
positive bacteria but have no effect on the growth of fungi or yeasts61. 
The structurally related f3-glycoside oleficin [3] was isolated as a deep red powder from a strain of 
Sireptomyces parvulus, and showed biological activity similar to the lipomycins63, with only the 
growth of Gram-positive bacteria being inhibited. Initially the structure was assigned as [46]64  but 
this was later revised such that oleficin [3] differs from cs-lipomycin [2] only in the length of the 
polyene chain65. Determination of the relative and absolute stereochemistry at C-14' and C-15' was 
likewise precluded as oleficin is also a waxy non-crystalline solid making X-ray studies 
impracticable (Scheme 21). 
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A third compound in this family, altamycin A [1], was isolated recently by Shenin. The structure 
was determined as [1] by the same protocols that had been used for oleficin and the lipomycins, and 
again the absolute stereochemistry at C-iO' and C-il' remained unresolved whilst that at C-5 was 
20 
found to be derived from the L-amino acid. Altamycin A [1] was found to contain a tetraene system 
as well as the -D-digitoxose moiety66; its biological activity was in accordance with the other 







The title compounds form the second group of natural products that contain the tetramic acid 
moiety; occurring as the 4-0-methyl ether, unsubstituted at C-3 and acylated on the ring nitrogen. 
The first member of this small class to be isolated was dysidin [48], a chlorine containing secondary 
metabolite of the Indo-Pacific sponge Dysidea herbacea 67•  The structure [48] was assigned after 
X-ray crystal studies; the C-5 substitution is so far unique amongst naturally occurring N-acyl-4-




Malingamide A [49],  a more complex chlorine containing derivative, was isolated from the marine 
cyanophyte Lyngbya majuscula68; its structure was assigned by chemical and spectral means. The 
same workers subsequently isolated69  seven related compounds from the same blue-green algae. 
They all lacked the fatty acid side chain of malingamide A [49] and were termed the pukeleimides 
(A to G), their structures being resolved by X-ray data (Scheme 24). 
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Aithiomycin [57]70,71  was isolated from Streptomyces aithioticus and has been the subject of 
attention for several groups72'73. Althiomycin [57] exhibits a broad spectrum of antibacterial 
activity against both Gram-positive and Gram-negative micro-organisms, although its instability 








1.3 SYNTHETIC ROUTES TO TETRAMIC ACIDS 
Gabriel achieved the first synthesis of a tetramic acid derivative in 1914. Reaction of 
phthalimidoisobutyryl chloride [58] with diethyl sodiomalonate gave [59], which on treatment with 
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SCHEME 26, reagents: (a) diethyl sodiomalonate; (b) conc. H2SO4. 
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Similar methodology was applied to the total synthesis of dysidin [48]. The acid chloride of (±)-
N-phthaloylvaline [61] was homologated to the ketoester [62] by reaction with the dianion of mono-
ethyl malonate. O-Methylation was carried out by treating [62] with potassium hydride and methyl 
fluorosuiphonate giving methoxy enol [63] which on treatment with hydrazine gave the 4-0-








SCHEME 27, reagents: (a) ethyl disodiomalonate; (b) KH,MeOS02F; (C) hydrazine. 
24 
The versatility of hippuryl chloride [65] and p-nitrophenyl hippurate [66] as intermediates in the 
synthesis of 3-substituted tetramic acids has been demonstrated76. Condensation of [65] or [66] 
with ethyl sodiocyanoacetate gives the corresponding benzoylaminoacetyl compound [68] in 
moderate yield; these were formed via the 2-phenyloxazolone intermediate [67]. Cyclisation of [68] 
using excess sodium ethoxide was observed to proceed with concomitant 	debenzoylation 
resulting in the formation of the 3-substituted tetramic acid [69]76  (Scheme 28). 
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SCHEME 28, reagents: (a) ethyl sodocyanoacetate; (b) NaOEt. 
The Dieckmann cycisation of N-acylaminoesters of the type [70] offers a route to the tetramic acid 
ring system which is potentially very versatile, and indeed this approach has received much 
attention. The formation of 1-benzyl-3-phenyltetramic acid [72] by treatment of [71] with sodium 
ethoxide was reported in 1950 and a series of 3-alkyltetramic acids has been prepared by this 











SCHEME 29, reagents: (a) NaOEt. 
In 1954, Lacey reported a convenient two step synthesis of 3-acyltetramic acids from readily 
available a-amino-esters79. This strategy has since become widely adopted in the construction of 
the tetramic acid ring. The original method involved condensation of an a—amino-ester [73] with 
diketene to give an acetoacetamide [74], which cyclised to the 3-acyltetramic acid [75] on exposure 

















SCHEME 30, reagents: (a) diketene; (b) NaOEt. 
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Tenuazonic acid [14] was prepared from ethyl L-isoleucinate and diketene by Miller and co-
workers23. Harris and colleagues22 similarly prepared a series of 3-acyltetramic acids from other 
amino acids in order to investigate their biological activity. Rinehart Jr. has investigated the 
applicability of this methodology to the synthesis of 3-dienoyltetramic acids related to streptolydigin 
[25] and tirandamycin A [27]80. However, in view of the basic reaction conditions, stereocontrol of 
the chiral centre at C-5 is very difficult. The condensation of dienoylacetyl esters [76] and [77] with 
a range of ethyl N-alkylglycinates [83] to give the corresponding acetoacetamides [81] and [82] was 
also published by Rinehart Jr. in the same paper80. When treated with sodium ethoxide the two 
acetoacetamides [81] and [82] afforded the dienoyltetramic acids [84] and [85] (Scheme 31). 
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SCHEME 31, reagents: (a) toluene 110°C; (b) NaOEt. 
Unfortunately, when an analogous condensation of ethyl tirandamycylacetate [86] (prepared from 
tirandamycic acid [28] and ethyl N-benzylglycinate [83]) was tried, only decomposition of the - 
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SCHEME 32 
The acylation of 3-unsubstituted pyrrolidine-2,4-diones was regarded as a promising alternative 
strategy in view of the requirement of an acyl substituent at C-3 (of the tetramic acid ring) in many 
of the biologically active natural systems. Kohl was the first to use this strategy, in the synthesis of 
magnesidin [18,19] 31. The value of this strategy in the synthesis of models of the complex 
naturally occurring 3-polyenoyltetramic acids was investigated by Jones81. Initial results were not 
encouraging as the product was being lost in the basic work-up required for the Lewis-acid mediated 
acylation. This problem was overcome by isolating the 3-acyltetramic acid products as their boron 
trifluoride complexes [88]. These were obtained in 50 - 78% yields via acylation of the pyrrolidine-
2,4-dione [87]. The 3-acyltetramic acids [89] were obtained by treatment of the complexes [83] 
with methano182 (Scheme 33). 
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SCHEME 33, reagents: (a) BF3OEt2; (b) MeOH. 
C-acylation of the thallium(I)enolate83 of a pyrrolidine-2,4-dione using an acyl fluoride to give the 
3-acyltetramic acid was investigated by Rinehart Jr.80. Thallium(I)enolate [90] when reacted with 
sorbyl fluoride [91] gave the C-acylation product [92], a model of streptolydigin [25], in only 4% 
yield. The major product [93] of the reaction arose from N-acylation of the C-5 side chain, with 
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SCHEME 34 
Acylation at C-3 of a pyrrolidine-2,4-dione clearly lacked the selectivity required for application to 
the synthesis of a naturally occurring 3-acyltetramic acid. Furthermore, as this strategy still relied 
on basic cyclisation of an N-acylaminoester for production of the tetrarnic ring, it would also not be 
possible to obtain 3-acyltetramic acids with a chiral centre at C-5. 
An alternative method of acylation at C-3 (of a pyrrolidine-2,4-dione) has been described by 
Jones84 and its applicability to the synthesis of complex 3-acyltetramic acids has been further 
investigated85'86'87. Directed metallation at C-3 of the 4-methoxypyrrol-2(5H)-one [94] gave the 
vinyllithium derivative [95] which when reacted with a range of aldehydes gave the hydroxy 
adducts [96] in good yields84. Oxidation of the adducts [96] with manganese dioxide gave the 
corresponding keto derivatives [97] which on treatment with sodium hydroxide liberated the free 3-
acyltetramic acids [98]. Extension of this methodology represented a method for the construction of 
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3-dienoyltetramic acids by nucleophiic reaction of organometallics of the type [99] carrying no 
activation at C-7 or protection at N-186 (Scheme 35). 
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SCHEME 35,reagents: (a) n- BuLi; (b) Mn02; (c) NaOH. 
Boeckmann88 reported the synthesis of a tetramic acid nucleus with the 3-acyl group suitably 
functionalised for further elaboration by means of a phosphonate-activated tetramic acid [102]. 
This was prepared by a modification of Lacey's method79 for synthesising tetramic acids. 
Phosphonate [100] was reacted with methyl glycinate under mild acid catalysis to give the 
phosphonoacetylacetamide [101] which cyclised, on treatment with sodium methoxide, to give the 
7-diethylphosphono-activated tetramic acid [102] (Scheme 36). 
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Some evidence was presented88 that the stereochemical integrity of a chiral centre at C-5 could be 
preserved. Although, in view of the basic reaction conditions used to perform the cyclisation, this 
could not be considered to be a synthetically reliable route to optically active 3-acyltetramic acids. 
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SCHEME 36, reagents: (a) NH2CH2CO2Me; (b) NaHCO3; (C) NaOMe. 
Tetramic acid [102] has been prepared by an alternative route90'91. The isoxazolium salt [103] was 
treated with sodium bicarbonate to induce fragmentation into the previously obtained 
acetoacetamide [101]. Again, this afforded the activated tetramic acid on treatment with base 
(Scheme 36) and likewise the same drawbacks are also applicable to this strategy. 
A modification of this technique was applied recently to the total synthesis of (-)-tirandamycin A 
[27]92. Reaction of the dianion of [104] (under milder conditions than previously possible) with 
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freshly prepared aldehyde [105] gave the Emmons adduct [106], which on treatment with 
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SCHEME 37 
The total synthesis of tirandamycin A in its racemic form has been achieved by Boeckmann93, 
Bartlett94(a) and Ireland94(') and, although this no longer represents the state of the art, the 
methodology employed is of some interest. Rosen and his colleagues at Abbott Laboratories95 used 
Schlessinger's92 phosphonate-activated tetramic acid strategy to prepare a long series of 3-
dienoyltetramic acids which were then evaluated according to their biological activity. The most 
potent agents in this series [107] had an unsubstituted naphthalene group attached to the terminus 
with a methyl group adjacent to the diene terminus (Scheme 38). The activities of these agents 
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SCHEME 38 
Now that the total synthesis of (-)-tirandamycin A [27]92 has been accomplished the synthetic 
horizon becomes the complex naturally occurring polyenoyltetramic acids which contain a chiral 
centre at C-5 of the Letramic acid nucleus. The research groups of Ireland96 and Schlessinger97 are 
independently pursuing the total synthesis of streptolydigin [25]. Ireland's group96 are investigating 
a strategy based on the acylation of a tetramic acid [108] with streptolic acid [26] whilst the latter 
group 97 are studying the use of his phosphonate-activated methodology, utilising the intermediates 


















Enantioselective total syntheses of fuligorubin A [3]99  and (+)-ikarugamycin [21]100,101  have 
been published recently. The chiral tetramic acid ring, in each case, is formed by Dieckmann 
cyclisation77 of chiral N-acetoacetyl-a-amino-esters using one'°1  or tw099'100 equivalents of 
potassium tert-butoxide as the base. The reaction, when carried out at 0 °C over a short period of 
time, is said to take place without any detectable racemisation occurring. Some doubt is cast over 
these results as one paper'0' offers no evidence in support of this. Two of the articles 99,100  do 
quote optical rotations that are in excellent agreement with those of the authentic materials. 
However, a subsequent study - by Poncet102 - of racemisation during the Dieckmann cyclisation, 
showed (by 'H n.m.r. and chemical correlation techniques) that non-negligible C-5 epimerisation 
(10 - 30%) occurs even under carefully controlled reaction conditions. This suggests that the method 
cannot be regarded as a reliable means for synthesising chiral tetramic acids. 
Last year Jones described103 a novel route to 3-acyltetramic acids which involves the ring-opening 
of a pyrone system. Treatment of bromomethyl pyrone [111] with sodium p-toluenesulphonamide 
afforded sulphonamide [112] which, when reacted with sodium methoxide, led to the formation of 
the nitrogen heterocycle [113]. The 3-acyltetramic acid [114] was easily obtained by alkaline 
hydrolysis of [113] (Scheme 40). Elaboration of the pyrone [111] at C-3 or C-7 would allow more 
complex tetramic acids (with sutstituents at C-5 or C-7) to be made using this strategy. 
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SCHEME 40, reagents: (a) NaNHT0s; (b) NaOMe; (c) NaOH(aq). 
The latest method to appear in the literature104 for synthesising tetramic acids employs a 5-exo-dig 
radical cycisation to form the heterocyclic ring. Exposure of a solution of the bromoamide [115] to 
tri-n-butyltin hydride in the presence of azo-bis-(isobutyronitrile) produced the crystalline lactam 
[116]. This was treated with ozone, using a triphenyiphosphine work-up, to obtain the 
corresponding tetramic acid [117] (Scheme 41). Attempted cyclisation of a bromoamide [118] 
lacking substitution at the propargylic methylene yielded (under analogous conditions) only the 















SCHEME 41, reagents: (a) n- Bu3SnH, AIBN; (b) ozone, MeOH, PPh3. 
Although promising methodology is available in the literature the problem of controlling the 
stereochemical integrity of the C-5 asymmetric centre of a tetrarnic acid has yet to be overcome 
satisfactorily. Consequently, the total synthesis of the complex chiral 3-polyenoyltetramic acids is 
still far from being a trivial exercise. 
1.4 SYNTHESIS OF POLYENES 
As one would expect from the vast array of naturally occurring biologically active compounds that 
contain a polyene unit, there has been an enormous amount of work carried out concerning the 
chemical synthesis of such systems. The literature in this field has been reviewed recently19J05  in 
depth and, as the methodology involved can be regarded mainly as a standard part of the organic 
chemist's range of techniques, a review of this area of organic chemistry will not be included herein. 
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2. DISCUSSION 
The general aim of this research project is to achieve the total synthesis of the naturally occurring 3-
polyenoyltetramic acid antibiotic altamycin A [1] and its stereoisomers as single enantiomers. The 
primary aim was, in view of the unfeasibility of X-ray crystallography, to firmly establish the 
absolute stereochemistry of the natural product. Secondly, it was intended that the synthetic route 
be of sufficient latitude to encompass the total syntheses of other related tetramic acids, namely a-
lipomycin [2] and oleficin [3] (Scheme 42). 
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SCHEME 42 
Once the aforementioned objectives have been reached, studies on structure-activity relationships 
will be facilitated, subsequently allowing a complete rationalisation of the structure and biological 
function of these intriguing compounds to be presented. 
The major synthetic hurdles are; the formation of a tetramic acid in an enantiomerically pure form, 
the construction of an all-trans polyene unit possessing two asymmetric centres with a 1,2 
relationship and the coupling of these to form the desired carbon skeleton. The sugar fragment, D-
digitoxose, is commercially available and has been synthesised106 previously so, consequently, the 
only problem is the selective formation of the glycosyl linkage in the -anomeric form. 
Careful consideration of the implications of the stereochemical features of altamycin A [1] resulted 
in a convergent approach to its total synthesis being envisaged from the retrosynthetic analysis 
shown (Scheme 43). This provided two target fragments for the synthesis of the aglycone of 
altamycin A [1].  The approaches to each of these intermediates and the investigation into the 
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SCHEME 43 
2.1 THE TETRAMIC ACID FRAGMENT 
Earlier work by Mitchell17 and Jenkins18 led to the development of a novel route to chiral tetramic 
acids which represents a significant breakthrough in the synthesis of complex naturally occurring 
tetramic acids. The tetramic acid is formed by the reaction of an oxazolidine-2,5-dione (an a- 
39 
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The mechanistic scheme makes it clear that two equivalents of the enolate are required. The first 
performs a nucleophiic attack at C-5 of the oxazolidine-2,5-dione [123] to give the 3-ketoester 
adduct [124]. The second equivalent of enolate selectively deprot.onates [124] at the 2-position 
resulting in the formation of dianion [125]. This enolate is stabilised by conjugation with the two 
functional groups CO2R and R3. In contrast to the problematic Dieckmann cyclisation of 
intermediates of the type [74] (Scheme 30), this conjugation with two functional groups results in 
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by the fact that deprotonation at the 4-position results in an enolate [129] which is not conjugated to 
any functional groups and therefore is significantly less stable than [125]. Loss of carbon dioxide to 
[126] and cyclisation to [127] then led to isolation of the tetramic acid [128] on acidification during 
work-up. As no deprotonation occurs at the 4-position, if an oxazolidine-2,5-dione which is chiral 
at C-4 is used, then the chirality will be transferred through to the tetramic acid without any 
racemisation taking place. 
Mitchell17 and Jenkins18 used this approach to prepare a range of teamic acids. The stereochemical 
integrity of those bearing a 5-[(1'S)-(l'-methyl)propyl] substituent at C-5 [131] was firmly 
established by 13C n.m.r. spectroscopy demonstrating that this novel route does indeed produce 
tetramic acids without C-5 epimerisation occurring (Scheme 45). 
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Application of this methodology to a ret.rosynthetic analysis of the tetramic acid fragment [120], 
required for the synthesis of altamycin A, makes it clear that the desired intermediate [120] will be 
formed by the reaction of oxazolidine-2,5-dione ((x—amino-acid-N-carboxyanhydride, NCA) [133] 
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SCHEME 46 
The chemistry, including methods of preparation, of a-amino-acid-N-carboxyanhydrides has been 
reviewed by Hirschmann107 showing that there are two main routes to this heterocyclic system. The 
Fuchs-Farthing method 108,109 involves the reaction of an a-amino-acid [134] with phosgene at 30 - 
60 °C in an inert solvent to produce the intermediate [135] which readily loses hydrochloric acid 
giving the NCA [123]. Leuchst10 described the alternative method involving the chlorination of an 
N-alkoxycarbonylamino-acid [136] which occurs with concomitant elimination of the alkyl halide 
during cyclisation to the desired product [123] (Scheme 47). 
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SCHEME 47, reagents: (a) phosgene; (b) thionyl chloride. 
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The Leuchs method was considered to be the more expedient of the two routes, especially if the N- 
methoxycarbonyl group is used, as the methyl chloride by-product of the cyclisation is very easily 
removed as well as being non-acidic. Jenkins18 had found that N-benzyloxycarbonyl urethanes gave 
very impure NCA derivatives, due to the presence of benzyl chloride, compared with the methoxy 
analogues. 
L-Glutamic acid [138] was acylated using methyl chloroformate (MOC-CI), in aqueous solution at 
pH 10.0, giving the urethane [139] as a white solid after trituration in petrol. The a-carboxylic 
acid group was then selectively esterified on treatment with one equivalent each of benzyl bromide 
and triethylamine in dry dimethylformamide. The benzyl ester [141] was purified by in Situ 
formation of the -dicyclohexylamine (DCHA) salt [140] followed by liberation of the free-acid 
with aqueous citric acid. Protection of the y-carboxylic acid function as the tert-butyl ester was 
achieved by reaction of [141] with isobutene (using acid catalysis) in a sealed tube at room 
temperature over ten days. The di-ester [142] was obtained, as a pale yellow syrup which could not 
be crystallised, in 90% yield. The benzyl ester group could be cleaved in two ways to give the tert- 
butyl mono-ester [143]. The first, and generally used procedure, was by alkaline hydrolysis with 
sodium hydroxide which afforded [143] as a white solid in 87% yield. The second procedure used 
was hydrogenolysis of the benzyl group in 10% aqueous methanol over a 10% palladium on 
charcoal catalyst. This gave [143] as before, albeit in slightly poorer yield (75%, Scheme 48). 
43 
CO2H 	(a),61% 	 CO 2H 
NH2 N M OC 
CO 2H 	
<\CO 2H  
138 	 139 
Co Bzl 	(c),98% 	
CO2BzI 
NMOC 	 NMOC 
H 	 K H 





CO2BzI 	(e) or (f),82% 	 CO2H 
IN 
NMOC 	 NMOC 
(H 	 (H 




SCHEME 48, reagents: (a) MOO-Cl, NaOH(aq); (b) (i) Bzl-Br, Et3N, (ii) DCHA; (C) citric 
acid, H20; (d) isobutylene, conc. H2SO4;  (e) 1.0 equivalent NaOH; (I) hydrogen, Pd-C. 
Benoiton's procedure111  for the racemisation free N-methylation of N-allcoxycarbonyl amino-acids 
caused two problems when urethane [143] was treated with sodium hydride in the presence of 
methyl iodide. The product [145] was very impure and it was isolated in poor yield (35%). 
Recrystallisation of the crude [145] proved difficult so a more effective means of purification was 
sought. Instead of isolating the alkylated material, the crude product was stirred in 50% ether-petrol 
with one equivalent (based on the starting material [143]) of cyclohexylamine which afforded the 
salt [144] as a white solid that was easily purified by recrystallisation from ethyl acetate-petrol. 
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Proton n.m.r. showed splitting of the methoxy and N-methyl signals due to the presence of cis and 
trans isomers of the urethane function. These result from hindered rotation about the amide C-N 
bond caused by its partial double bond character. Treatment of the salt [144] with aqueous citric 
acid gave the free-acid [145] as a white solid in a yield of 94% (Scheme 49). The N-methyl amino-
acid [145] had an optical rotation of -24.20 and n.m.r. spectroscopy again indicated that the 



















SCHEME 49, reagents: (a) (I) Mel, NaH, (ii) CHA; (b) citric acid, H20. 
The N-methylurethane [145] was treated with freshly distilled thionyl chloride at 0 °C for five 
minutes, the excess thionyl chloride was then removed in vacuo. The residue was warmed to 55 °C 
(to bring about the cyclisation) whilst the pressure was maintained at circa 5 ton to ensure the 
complete removal of the by-products. Once cool, the flask was brought to atmospheric pressure and 
the residue triturated with petrol to give (S)-4-[2'-(zert-butyloxycarbonyl)ethyl]-3-










SCHEME 50, reagents: (a) thionyl chloride. 
The i.r. spectrum of NCA [133] showed three carbonyl stretching bands at 1850, 1785 and 1725 
cm indicating that a cyclic anhydride group was present. As anhydrides of this type are sensitive 
to moisture as well as heat care was taken to ensure the compound never became exposed to such 
harmful conditions. 
As mentioned earlier, the 3-isoxazolyltetramic acids have been found18 to be excellent precursors 
for 3-acyltetramic acids because they are readily converted, in a one-pot hydrogenation and 
hydrolysis sequence, to the 3-acetoacyltetramic acids. The required ester, needed for reaction with 
the NCA [133], was prepared from the readily available 3,5-dimethylisoxazole [146] using 
Micetich's method 2. Deprotonation of the 5-methyl group with n-butyllilhium followed by 
reaction of the anion with dry carbon dioxide gave, on acidic work-up, the carboxylic acid [147]. 
Esterification of this acid using ethereal diazomethane produced the desired acetate ester [148] in 
good yield (Scheme 51). 
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SCHEME 51, reagents: (a) (I) n- BuLl, CO2, (ii) H30; (b) diazomethane. 
The use of diazomethane in the esterification step was found to be inconvenient as only small 
quantities could be prepared at any one time so, as a fairly substantial quantity of the ester [133] was 
required, an alternative methylation strategy was necessary. Initial attempts at methylation of the 
lithium salt [149] with methyl iodide in dry dimethylformamide and anhydrous HC1-methanol were 
me 
unsuccessful. This was attributed to the fact that the small lithium cation was too tightly bound to 
the carboxylate anion. The problem was circumvented by utilisation of Wang's113 esterification 
procedure, where the caesium salt of a carboxylic acid is reacted with an alkyl halide to form the 
ester. The caesium salt [150] was prepared by titrating an aqueous solution of the acid [147] to pH 
7.0 with 20% aqueous caesium carbonate then lyophilising the neutral solution. The methyl ester 
[148] was obtained by stirring the salt [150] with methyl iodide in dimethylformamide (Scheme 52). 
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SCHEME 52, reagents: (a) H30; (b) 20% CsCO3(aq); (C) Mel. 
Reaction of the oxazolidine-2,5-dione [133] with two equivalents of the lithium enolate of methyl 3-
methyli sox azole-5-acetate [132] for four hours gave (5S)-5-[2'-(terr-butyloxycarbonyl)ethyll -1-
methyl-3-[5"-(3"-methylisoxazolyl)]tetramic acid [120] on acidification (pH 1.0) of an aqueous 
solution of the reaction products (Scheme 53). The tetramic acid [120], obtained as a white 
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SCHEME 53, reagents: (a) (I) 2.0 equivalents [132], TMEDA ,(ii) H30+- 
2.2 PREPARATION OF THE NONADIENAL UNIT 
Retrosynthetic analysis of altamycin A [1] showed the nine carbon a43-unsaturated aldehyde 
derivative [121] to be the best intermediate building-block for the right hand side of the molecule. 
Analysis of the polyenal [121] makes it clear that an aldehyde [151] forms a key synthon for [121]. 
The Sharpless114 epoxidation could then be used to prepare an enantiomerically pure epoxide of the 
type [152], the cuprate ring-opening of which would lead to the requisite aldehyde [151] (Scheme 
54). 
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Lewis19 and Jenkins18 had pioneered the synthesis of nonadienal [121] and their synthetic route was 
used, with only minor modifications, in this work. 
Titanium tartrate mediated asymmetric epoxidation of allylic alcohols, first reported by Sharpless1 '4 
in 1980, has been widely recognised as being a tremendously useful way of introducing (with high 
enantioselectivity) chirality into achiral substrates. The mechanism of this reaction115'116 has been 
given some considerable attention and the structural as well as stereoclectronic characteristics 117 
have also been studied. The interest in asymmetric epoxidation in this research, however, was from 
a purely synthetic perspective and this has been covered by the publication of review articles 118,119.  
The absolute stereochemistry of the epoxy alcohol obtained from a given tartrate ester is illustrated 
in Scheme 55 and has been shown to be reliable for a wide range of substituted allylic 
alcohols 114,115. 
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L-(+)-diethyl tartrate (natural) 
SCHEME 55, reagents: (a) tartrate, Ti(Oi- Pr)4, t- BuOOH. 
The above scheme allows one to predict which product will be obtained from either the cis- or 
trans- allylic alcohols. Thus we can prepare all four possible diastereoisomeric epoxides and hence 
HO— 160 
çs)s) 	 (R,R) 	 (f ) ) 	 (S1 ) 
SCHEME 56, reagents: (a) L -(+)-DET, Ti(Oi- Pr)4, t- BuOOH; (b) as for (a) except 
D - (-)-DET. 
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The allylic alcohol [155] required for the Sharpless epoxidation was prepared by Wittig 
condensation of the stabilised ylide carboethoxymethylidinetriphenylphosphorane and 
isobutyraldehyde [153] to give the a,13-unsaturated  ester [154]. The trans relationship of the two 
vinylic protons was confirmed by the 15.7 Hz coupling constant observed for the signals at 8 5.74 
and 6.92 p.p.m. in the proton n.m.r. spectrum. Reduction of this ester with three molar equivalents 
of diisobutylaluminium hydride (DIBAL) gave the isomerically pure trans-allylic alcohol [155] as a 
clear, colourless liquid in 91% yield (Scheme 57). 
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SCHEME 57, reagents: (a) EtO2CCH=PPh3; (b) DIBAL, -78°C. 
Asymmetric epoxidation of [155] was achieved in 70% yield via the catalylic procedure described 
by Sharpless120  (Scheme 58) using his modifiedll5(a)  dimeth4ulphide work-up. The catalytic 
method uses only 10 mol % titanium tetraisopropoxide and 13% mol % L-(+)-diethyl tartrate so 
purification of the epoxy alcohol [157] is much easier than in the stoichiometric procedure. 
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SCHEME 58, reagents: (a) L- (+)-DET, Ti(Oi- Pr)4, 1- BuOOH, 4A sieves; (b) DMS, NaF. 
The optical rotation of [157] was -34.81  (c = 1.02 in chloroform) which concurred with the results of 
Lewis19, who carried out a detailed study of the optical purity of the product from the catalytic 
reaction. Lewis found19 that none of the other enantiomer [158] (Scheme 58) could be detected on 
exposure of a solution of [157] to a europium(III) chiral shift reagent; id est no signals due to [158] 
were observed in the proton n.m.r. spectrum. Sharpless had noted120 that the enantioselectivity was 
more variable in the catalytic reaction as even small amounts of moisture could interfere with the 
catalyst, so recommended the use of finely powdered 4A molecular sieves to ensure completely 
anhydrous conditions. Indeed, by following his recommendations and thoroughly drying all 
glassware prior to use, the catalytic method was found to yield products whose optical purity was 
equal to that of epoxy alcohols prepared by the stoichiometric method. 
Kishi121 had demonstrated the high regio- and stereoselectivity of chiral epoxide ring-opening 
reactions using organocuprates. Lewis19 and Jenkins18 found that the highest regioselectivity was 
obtained when the hydroxyl function of the epoxy alcohol was left unprotected. A reaction 
temperature of -40 °C gave a regioselectivity of 8:1 in favour of the desired regioisomer, which was 
obtained in good yield. They could achieve higher yields by varying reaction temperature but this 
resulted in poorer regioselectivity. Thus, epoxy alcohol [157] was treated with 7.5 equivalents of 
lithium dimethylcuprate at -40 °C in fydrous ether for eighteen hours which gave, after purification 
by flash column chromatography (to remove small amounts of the regioisomer [162] caused by 
attack at C-3 of the epoxy alcohol [157]), the desired 1,3-diol [161] as a cream low-melting waxy 
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SCHEME 59, reagents: (a) Me2CuLi, -40 0C 
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The enantiomer of [161] had been prepared by Baker and co-workers122, as an intermediate in the 
synthesis of avermectins, who reported its optical rotation to be +16.5° (c = 1.1 in dichioromethane). 
It was found that the 1,3-diol [161] gave an optical rotation of -20.80 (c = 1.4 in chloroform) 
indicating that the required 2R,3S stereochemistry was present. 
Protection of the secondary hydroxyl function, thus allowing the C-3 hydroxyl group to be oxidised 
selectively, could not be performed directly on diol [161] so a circuitous route was employed. The 
primary hydroxyl group of [161] was esterified with benzoyl chloride in dry pyridine producing 
benzoate [163]. Silylation of the hindered secondary hydroxyl group needed fairly strong reaction 
conditions (tert-butyldimethylsilyl chloride, imidazole and 4-dimethylaminopyridine at 50 °C) and a 
reaction time of five days before the orthogonally protected diol [164] could be obtained in a 
satisfactory yield (93%). Methanolysis of the benzoate ester with Claisen's alkali afforded the 
monoprotected diol [165] in 95% yield (Scheme 60). 
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SCHEME 60, reagents: (a) PhCO-CI, pyridine; (b) TBDMS-CI, imidazole, DMAP, 50 00; 
(c) KOH, MeOH. 
Oxidation of the primary alcohol [165] had been effecte&9 by a modified Moffat oxidation which 
gave crude material of sufficient purity to allow its use without chromatography. Ley and Griffith 
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developed123 the novel catalytic oxidant, tetra-n-propylammonium per-ruthenate (TPAP) which is 
used with N-methylmorpholine IV-oxide as a co-oxidant. This reagent is a very mild system and 
gives excellent yields of the aldehydic compounds. It should also be noted that any chirality in the 
substrate is completely unaffected by this oxidation. For these reasons, the decision was taken to 
use the catalytic ruthenium-based method in the preparation of the required aldehyde [166]. In a 
typical reaction, the alcohol [165] was dissolved in dry dichloromethane then N-methylmorpholine 
N-oxide (1.5 equivalents) and powdered 4A molecular sieves were added. Finally, TPAP (0.005 
equivalent) was added and the resultant green mixture stirred at room temperature for sixteen hours 
overnight. The reaction mixture was diluted with dichloromethane then washed with aqueous 
sodium sulphite, brine and aqueous copper(II)sulphate. Concentration of the dried organic liquors 
gave the crude product which was purified by dry flash chromatography to give the desired aldehyde 








SCHEME 61, reagents: (a) n- Pr4NRuO4 , NMNO, 4A sieves. 
Now that the chiral aldehyde [166], which would form one end of the polyene chain, had been 
prepared the next task was to build the all trans diene unit on to the optically active pentanal 
intermediate. Antecedent work by Lewis19 had demonstrated that the most expedient route to the 
polyenal fragment was construction of the olefinic bonds one at a time. Although more laborious 
than using reagents that already contained unsaturated units, it was found to be far more reliable 
when the question of isomeric purity of the double bonds arose. To this end, aldehyde [166] was 
condensed with the stabilised phosphorane [170]124 which gave enone ester [167]. 
In order to achieve satisfactory yields of the product a reaction time of five days in refluxing 
benzene was necessary. Carbomethoxyethylidinetriphenylphosphorane [170] was prepared by 
reacting (±)-methyl 2-bromopropionate [168] with triphenylphosphine then treating the precipitated 








169 	 170 
Ox 	 ox 
(c),79% 




SCHEME 62, reagents: (a) PPh3; (b) NaOH(aq); (c) [1701, benzene, 80 °C 
The nuclear Overhauser effect (n.O.e.) provided an excellent means19 of confirming the double 
bond geometry: irradiation of the 2-CH3 at S 1.84 gave rise to a notable 5.9% enhancement of the 
4-H resonance at 5 2.56 - 2.72 (Scheme 63). Consequently the 2-CH3 and 4-H moieties must be 
close in space, and the only way this can happen is if the olefin is of trans geometry. In the cis 
compound [171] one would expect to see no enhancement of the 4-H resonance but an effect on the 
3-H signal (Scheme 63). 
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Previously, the ester function in [167] had been reduced and the alcohol subsequently oxidised to 
afford the aldehyde. Obviously if the ester could be reduced to the aldehyde in a single step this 
would result in a much shorter synthesis. Unfortunately, the chemical literature is devoid of reliable 
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methods to carry out this transformation so an effort was made to solve this problem. 
Mechanistically, the reduction of esters with DIBAL seemed to offer the best prospect for finding a 
viable solution to this problem as the corresponding aldehydes are intermediates formed on the way 
to the alcohols. It was hoped that silylation of the acetal intermediate [172], achieved by doing the 
reaction in the presence of a silylating agent, would prevent formation of the aldehyde [173] during 
the reduction and hence stop production of the alcohol [174] (Scheme 64). 
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SCHEME 64 
The hypothesis was tested by carrying Out the reduction of ethyl cinnamate [175], using DIBAL (1.0 
equivalent) and trimethylsilyl chloride or 1,1,1-3,3,3-hexamethyldisilazane (1.0 equivalent) at -40 
°C and -95 °C. In all cases the product mixture (obtained in excellent yield) consisted of [175] and 
cinnamyl alcohol [177] in a ratio of 2:1 as observed by proton n.rmr. spectroscopy. Only a trace of 
cinnamaldehyde [176] was observed as a third spot on t.l.c. (Scheme 65). 
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SCHEME 65, reagents: (a) DIBAL, TMS-Cl, -40 or -95 OC;  (b) DIBAL, HMDS, -40 or 
-95°C. 
Thus, ester [167] was reduced to the allylic alcohol [178] using DIBAL at -78 °C in 69% yield. 
Oxidation of [178] was accomplished by treatment with TPAP and N-met.hylmorpholine N-oxide. 
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The pure unsaturated aldehyde [179] had an optical rotation of +4.70 and showed a X max at 233 urn 
in the u.v. spectrum. The olefinic chain of [179] was then extended by a Wittig reaction using 
ethoxycarbonylmethylenetriphenylphosphorane in benzene at reflux for five days. The pure (E,E)-
diene [180] was obtained (95% yield) after chromatography on silica gel. Proton n.m.r. 
spectroscopy showed a coupling constant of 15.5Hz between the 2-H and 3-H resonances at 8 7.34 
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SCHEME 66, reagents: (a) DIBAL, -78 00;  (b) TPAP, NMNO, 4A sieves; (c) 
Et02CCH=PPh3, 80°C. 
Synthesis of the polyenal fragment was completed by transformation of the ethyl ester [180] into the 
corresponding alcohol [181] using DIBAL as the reducing agent. This alcohol was then oxidised, 
with the catalytic TPAP/NMNO system, to afford the aldehyde [182] which had been identified as 
the synthon for the polyene unit of our target system. [182] had an optical rotation of +4.60 and a 
max of 279 nm with the proton n.m.r. spectrum again showing that the all-trans geometry was 
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SCHEME 67, reagents: (a) DIBAL, -78 °C; (b) TPAP, NMNO, 4A sieves. 
2.3 STUDIES TOWARDS COUPLING THE KEY INTERMEDIATES 
Coupling the tetramic acid and dienal fragments represents the point of convergence in this 
synthetic route. Consequently, this step forms the crux of the modus operandi so any chemical 
reaction employed to achieve the union of the intermediates must be both selective and high-
yielding. 
Jenkins prepared18 the 3-butenoyltetramic acid [185] with a view to utilising the masked enone 
moiety as a means of producing the reactivity required for coupling to an electrophile. The latent 
1,3-dicarbonyl functionality of the isoxazolyltetramic acid [120] was unmasked via a one-pot 
hydrogenation/hydrolysis procedure. This gave the acetoacetyl derivative [183] in a yield of 85%. 
Proton n.m.r. spectroscopy indicated that the 1,3-diketo compound was present as the 2'-CH2 
showed a resonance at 5 3.98. Jenkins elaborated18 [183] into the 3-butenoyltetramic acid [185] by 
reduction of the 3'-carbonyl group with sodium borohydride followed by acid-catalysed dehydration 
of the resulting alcohol [184] (Scheme 68). 
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SCHEME 68, reagents: (a) (i) hydrogen, Pd-C, () H30; (b) NaBH4; (c) TosOH. 
Rather than continue with the development of the Jenkins' approach18 it was attractive to pursue a 
less cumbrous route. This, it was hoped, would lead to a much more efficient (with respect to both 
time and materials) synthetic route to the target structure. 
The most obvious way of reducing the length of the synthesis is by combining the coupling and 
tetramic acid ring-forming steps. This could be achieved if the enolate used to attack the N-
carboxyanhydride [133] was part of the polyerie unit [186] (Scheme 69). 
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SCHEME 69 
Reaction of polyunsaturated aldehyde [189] with the phosphonate [100]8889  would give the 
substituted 1,3-diox-5-enone [190] which on treatment with methanol then base would produce the 
desired enolate species [186] (Scheme 70). 
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Boeckmann's procedure89 was followed in an attempt to prepare the phosphonate [100]. 
Accordingly, 2,2,6-trimethyl-1,3-diox-5-en-4-one [191] was chlorinated at the 6-methyl position by 
treatment of the corresponding lithium enolate with hexachioroethane. The chloride [192] was then 
stirred with the potassium salt of diethyl phosphite. Unfortunately, the 6-diethyiphosphonomethyl 
compound was obtained in very poor yield (19%) and always contained a trace of impurity as 
evidenced by the presence of a second spot on t.l.c. (Scheme 71). 
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SCHEME 71, reagents: (a) (I) n- BuLl, C2C16, (ii) KOt - Bu, H(0)P(OEt)2. 
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Due to the significant problems of poor yield and arduous purification the related phosphorane 
[195]88 was seen as a superior reagent because of the ease of preparation. Dioxenone [191] was 
brominated at the allylic methyl position using N-bromosuccinimide in carbon tetrachloride at 
reflux. The crude bromide [193] (a lachrymatory oil) was added to a solution of triphenyiphosphine 
in toluene and the phosphonium salt [194] precipitated out. The white salt [194] was then shaken 
with aqueous potassium carbonate to generate the phosphorane [195]. Ylide [195], isolated as 
green-yellow crystals, appeared to be stable for long periods if stored at -20 °C in a freezer (Scheme 
72). Other methods which were tried in an effort to obtain [195] (id est DABCO and aqueous 
sodium hydroxide) led to decomposition of the phosphonium salt [194]. 
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SCHEME 72, reagents: (a) NBS, CCI4, reflux; (b) PPh3; (c) potassium carbonate (aq). 
Phosphorane [195] was then reacted with crotonaldehyde [196] (chosen as a model for the 
unsaturated aldehyde [189] that would be reacted with [195] to produce the required intermediate 
[190]) under a variety of conditions to try to find the best procedure for the Wittig coupling 
(Scheme 73). 
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Initially, the reaction was carried out at room temperature which led to the isolation of a 1:1 mixture 
of cis and trans isomers [197] in varying yields; the results are summarised in the following table: 
Solvent 	% Yield [197] 	 tJdays 
Toluene 	no reaction 	 3 
CH3CN 	5 	 3 
CH2C12 	8 	 6 
Benzene 	19 	 3 
DMSO 	12 	 6 
To try and improve the yields of desired product the reaction was carried out at 40 °C over three 
days. These experiments gave the trans diene [198], with 2 max 303 nm, and a bicyclic product 
[200] which had ? max 223 nm in the u.v. spectrum. This product arises from thermally induced 
electrocyclisation of the three pi-bonds in the cis product [199]. Only cis orientation of the diene 
allows the molecule to obtain the necessary planar arrangement that facilitates such a cyclisation 
(Scheme 74). 
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The yields of desired product in the elevated temperature runs, although better, were still 
unacceptable, as can be seen from the table (vide infra). In both cases, the rest of the material 
recovered from the crude reaction product was a yellow solid (eluted from the silica column with 
acetone). This solid, which could not be identified, had a very broad u.v. absorption of 200 - 350 
nm and probably resulted from decomposition of the phosphorane species [195]:- 
Solvent T/°C % yield [198] % yield [200] 
CH3CN 40 11 9 
CH2C12 40 8 8 
Benzene 40 12 9 
DMSO 40 12 10 
It was reasoned that phosphorane [195] would react more readily with an a43-saturated aldehyde. 
With this in mind, pent-4-enal [202] was prepared by oxidation of pent-4-en-1-ol [201] using 
pyridinium chlorochromate. Wittig reaction of [195] and [202] in dry benzene at 40 °C followed the 
same pattern as before with the adduct [203] being isolated in only 21% yield (Scheme 75). Only 
the trans isomer was isolated after irradiation of the crude mixture with a tungsten lamp (500W). 
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The inefficacious addition of the dioxenone unit via phosphorus methodology meant that an 
alternative procedure was sought after. Treatment of the trimethyldioxenone [1911 with 
n-butyllithium followed by trimethylsilyl chloride generated trimethylsilyloxy diene [204] in situ. 
This was then used to perform a Lewis-acid catalysed aldol reaction on crotonaldehyde [196] 
at -78 °C. 
Catalytic quantities of tin(IV)chloride and zinc(II)iodide were used in separate experiments. In both 
cases, only the Michael-addition product [205] was isolated with none of the expected 1,2-addition 
compound [206] being observed (Scheme 76). This result was somewhat surprising as it is well 
known125 that a,f3-unsaturated aldehydes normally undergo 1,2 addition. Obviously the method was 
of little use for the purpose of this work and hence was not investigated any further. 
205 
SCHEME 76, reagents: (a) n- BuLi, TMSCI, -78 °C (b) [196], SnCI4 or ZnI, -78 °C 
The acetoacetate system represents another way of introducing functionality from which an enolate 
species could be generated. Bodalski had reported126 the preparation of ethyl 4-(diethylphosphono)-
3-oxobutyrate [209] and described its use in introducing the 13-ketoester unit. Thus, ethyl 4-bromo-
3-oxobutyrate [208] was converted to its sodium salt then treated with sodium diethylphosphite. 
The crude material showed a signal at 6 18.98 in the phosphorus n.m.r. spectrum which is consistent 
with a phosphonate species126 but, on distillation, the material decomposed. Compound [208] was 
prepared exactly according to Duthailer's127 method; ethyl acetoacetate was brominated at the 2- 
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position with liquid bromine then oxygen was passed through the reaction mixture to effect 
rearrangement to the 4-bromo derivative [208] (Scheme 77). 
SCHEME 77, reagents: (a) (I) Br2(I),-10 O,  (ii) 02(g); (b) (i) NaH, 0 °C, (ii) NaP(0)(OEt)2. 
The related dimethylphosphonate [211] was prepared, in the same manner, from methyl 4-bromo-3-
oxobutyrate [210]127. Again, attempts to purify the crude phosphonate led to decomposition - 
despite literature reports to the contrary126. Crotonaldehyde [196] was reacted with the dianion of 
crude [211] to give the dienone [212] in 25% yield after chromatography (Scheme 78). Proton 
n.m.r. spectroscopy of [212] showed that there was circa 22% of the enolic form [213] present. The 
u.v. spectrum showed a bathochromic shift when a drop of sodium hydroxide was added to the cell: 
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SCHEME 78, reagents: (a) (I) NaH, (ii) NaP(0)(OMe)2, 0 °C; (b) (I) NaH, 0 OC,  (ii) [196]. 
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The lack of success with both of the phosphorus reagents led to the combined tetramic acid-
formation and coupling protocol being abandoned. Instead attention was turned to exploitation of 
the reactivity of isoxazoles. 
The acidity of a-hydrogens of 3-, and especially, 5-alkyl side chains on isoxazole rings is enhanced 
by the ring nitrogen128. Aldol-type condensations involving such groups have been known for many 
years and can be performed without additional activation if strong bases (exempli gratia alkyl-
lithium compounds and lithium dialkylamides) are employed129. In 3,5-dimethylisoxazoles [214] 
the 5-position is the more reactive. So treatment of [214] with n-butyllithium then an electrophile 
gives the 5-substituted derivative [2151129.  Lithiation of the 3-methyl group will now take place in 
an analogous fashion using sec-butyllithium130'131 (Scheme 79). 
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SCHEME 79, reagents: (a) n- BuLi, E; (b) s- BuLi, E 
In the isoxazolyltetramic acid [120] only the 3-position of the isoxazole has a substituent bearing a- 
hydrogens. Lithiation of this group should occur readily on treatment with an appropriate base. To 
this end, [120] was treated with n-butyllithium at -78 °C in dry tetrahydrofuran. Crotonaldehyde 
[196] was then added to the yellow solution and the mixture was stirred for four hours. Analysis of 
the crude product indicated that the desired aldol product [217] had been formed, with the u.v. 
spectrum showing X max 268 nm and 315 nm. High resolution (FAB) mass spectrometry detected 
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SCHEME 60, reagents: (a) (i) n- BuLi (2.0 equiv.), [196], (ii) H30. 
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The coupling was tried utilising lithium diisopropylamide and likewise sec-butyllithium as the 
deprotonating agents. The experimental results were similar to the previous attempt where the 
complex reaction products contained, inter alia, starting material and [217]. 
Ethyl cinnamate [175] was reacted with the lithio derivative of [1201 (generated using sec-
butyllithium) to determine if the more electrophilic ester carbonyl group would react in a superior 
fashion to that of an aldehyde. The product obtained was the di-ester [219], resulting from attack by 
the oxygen of the enolate ion, and not the desired enone [220] (Scheme 81). 
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SCHEME 81, reagents: (a) s- BuLi (2.0 equiv.), [1751, -78 °C. 
This seemed to indicate that reaction occurred preferentially at the oxygen anion (formed by 
deprotonation of the enol with one equivalent of the base) which, in the case of an aldehyde as the 
Me 
electrophile, would result in the formation of a hemi-acetal. Such a species would, of course, be 
hydrolysed back to the enol during acidic work-up. Blocking this nucleophilic site with a silicon-
based group should lead to selective reaction at the carbanion. 
To achieve this, one equivalent of sec-butyllithium was added to the tetramic acid [120] followed by 
an equivalent of tert-butyldimethylsilyl chloride. A second equivalent of sec-butyllithium was 
introduced then succeeded by one equivalent of the aldehyde [196]. After three hours at -78 °C the 
reaction was worked up. The product [217] was obtained as a green solid foam. Spectral data 
concurred with the predicted structure; the u.v. spectrum showed ?. max 239 and 272 nm which upon 
addition of base shifted to X max 271 and 306 nm confirming the presence of the tetramic acid unit. 
When [217] was heated to reflux in dichloromethane with a crystal of p-toluenesulphonic acid, the 
u.v. spectrum showed ?. max of 269, 304 and 358 nm. This indicated that water had been eliminated 








SCHEME 82, reagents: (a) (I) s- BuLi (1.0 equiv.), TBDMS-CI, -78 Ot, (ii) s BuLl (1.0 
equiv.), [196], -78 oC,  (iii) H30-- 
Now that a coupling method finally showed promise the reaction was carried out using the 
nonadienal fragment [182] as the electrophile (Scheme 83). Disappointingly, analysis of the crude 
complex reaction products by t.l.c., proton n.m.r. spectroscopy and u.v. spectroscopy showed that 
mainly starting materials were present. The high resolution (FAB) mass spectrum showed an ion 
633.39353 (calc. for C341157N207Si: MH, 633.39348) which does correspond to the coupled 
species. 
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SCHEME 83, reagents: (a) (i) s- BuLi (1.0 equiv.), TBDMS-CI, -78 °C, (ii) S BuLl (1.0 
equiv.),[182], -78 00,  (iii) H30+- 
These results illustrate that the aforementioned methodology represents a viable means of achieving 
the coupling of [120] and [182]. Obviously, there is room for improvement in the procedure and 
this might be accomplished through further scrutiny. 
2.4 SUMMARY AND FUTURE WORK 
The synthesis of the two key intermediates, namely (5S)5[2'(tertbutyloxycarbonyl)ethyl]-1- 
methyl-3-[5"-(3"-methylisoxazolyl)]tetramic 	acid 	[120] 	and 	(2E,4E;6R,7S)-7-(tert- 
butyldimethylsilyloxy)-4,6,8-trimethylnona-2,4-dienal [182], has been executed in an 
enantioselective manner. 
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The coupling of these key fragments has been the subject of thorough investigation. Consequently, 
a protocol for the accomplishment of this objective has been elucidated, though further work is 
required to realise its full potential. Reductive cleavage of the isoxazole ring134 (of the dehydration 
product [223]) with samarium diiodide then reduction of the resultant enamine with sodium 
cyanoborohydride would give the 3—amino-ketone [224]. Quaternisation of the amino group would 
facilitate a base-catalysed elimination of the quaternary ammonium salt giving, after deprotection, 
the aglycone of aliarnycin A [225] (Scheme 84). 
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SCHEME 84, reagents: (a) Sm12, MeOH; (b) (I) Mel, base, (ii) TFA. 
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Future research could investigate other coupling strategies based around the tetramic acid unit, 
exempli grazia alternative methodologies for activation of this moiety. The final synthetic hurdle to 
be overcome will be to form the 3-0-glycosidic linkage with D-digitoxose. Hopefully, this should 
be straightforward as there has been very considerable research carried out in this field132. 
Finally, this research has potentially unearthed the key which can (in futurus) unlock the door to a 
complete understanding of the biological, chemical and pharmacological behaviour of these, and 
related, natural products. 
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3. EXPERIMENTAL 
All solvents were distilled before use. Unless otherwise stated, petrol refers to the fraction of 
petroleum ether boiling in the range 40 - 60 °C. Benzene, toluene and diethyther (ether) were 
dried by storage over sodium wire. Dichloromethane, dimethylformamide and acetonitrile were 
dried by distillation from calcium hydride. Tetrahydrofuran was dried by distillation from sodium 
benzophenone ketyl immediately before use. Chloroform and carbon tetrachloride were dried by 
distillation from phosphorus pentoxide and methanol was dried by distillation from magnesium-
iodine. DimethYlkulPhoxide was dried by distillation from lithium aluminium hydride at reduced 
pressure and was stored under nitrogen over 4A molecular sieves. Diisopropylamine, pyridine, 
teiramethylethylenediamine (TMEDA) and triethylamine were all distilled from potassium 
hydroxide pellets and stored over 4A molecular sieves. Dry carbon dioxide gas for carboxylation 
reactions was obtained by sublimation of commercially available dry-ice followed by passage 
through concentrated sulphuric acid then through a column of silica gel desiccant. All other 
purchased chemicals were used as received. Every reaction involving the use of strong bases and air 
or moisture sensitive reagents was performed in oven dried glassware (at 140 °C) under an argon 
atmosphere. The argon for such experiments was purified by passage through columns of silica gel 
(60H, impregnated with chromium trioxide) and silica gel desiccant. 
Ethereal solutions of diazomethane were prepared from N-methyl-N-nitroso-p-toluenesulphonamide 
using an 'Aldrich "mini-diazald" apparatus. 
Flash column chromatography refers to the technique described by Stil1133. 	Dry flash 
chromatography was carried out on 'Merck' Kieselgel 60H. The technique involved a cylindrical 
glass sinter (porosity 3) being filled with silica which was compacted by applying suction and 
pressing it down with a flat spatula. The column was solvated with the least polar component of the 
intended eluent and sucked dry. The mixture to be separated was dissolved in the minimum volume 
of the least polar solvent then loaded, as evenly as possible, to the top of the column. Elution with 
equal volumes of solvent mixtures of increasing polarity, ensuring that the column was sucked to 
dryness between fractions, then effected the desired purification. Thin layer chromatography (t.l.c.) 
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was carried out on aluminium sheets precoated with silica gel 60G F-254 (Merck 5735) in the 
following solvent systems: (A) ether, (B) 50% ether-petrol, (C) 30% ether-petrol, (I)) 20% ether-
petrol, (E) 10% ether-petrol, (F) 5% ether-petrol, (G) petrol, (H) 20% ethyl acetate-hexane and (I) 
ethyl acetate. Visualisation of the compounds was achieved by a suitable combination of the 
following methods: iodine vapour, u.v. absorption at 254 or 366 nm, neutral potassium 
permanganate solution/bromophenol blue solution and 6M sulphuric acid solution. 
Infrared spectra were recorded on a Perkin Elmer 781 spectrophotometer in the solvent indicated. 
Ultraviolet spectra were recorded on a Varian Cary 210 spectrophotometer. Mass spectra and high 
resolution mass spectra were recorded on a Kratos MS50TC spectrometer with xenon as the 
bombardment source. 'H n.m.r. spectra were recorded on either Jeol PMX60 (60MHz), Bruker 
WP80 (80MBz), WP200 (200MHz) or WH360 (360MHz) machines in fully dueterated solvents, 
with tetrarnethylsilane (TMS) as the external standard ( öj/ppm 0.00). 13C n.m.r. spectra were 
recorded on either Bruker WP200 (50MHz) or WH360 (90MHz) machines with TMS as the external 
standard (öc/ppm  0.00). 31P n.m.r. were recorded on a Jeol FX90Q (36M11z) machine with 85% 
aqueous phosphoric acid as the external standard (p/ppm 0.00). Optical rotation [a] values were 
determined on an Optical Activity AAI000 automatic polarimeter using a 10.0 cm (1.0 dm) cell at 
589 nm (sodium D line). Elemental analyses were carried out on a Carlo-Erba elemental analyser 
model 1106. Melting point determinations were carried out on a Kofler hot-stage microscope and 
are uncorrected. 
N-Methoxycarbonyl-L-Glutamic acid 1131 (MOC-Glu) 
L-Glutamic acid (147.1 g, 1 mol) was dissolved in a mixture of sodium bicarbonate (1M(aq); 1 dm3) 
and sodium hydroxide (4M (aq); 800 ml) and the stirred solution was cooled in an ice/salt bath. 
Methyl chloroformate (142.0 g, 1.5 mol) was then added dropwise over 30 minutes before the 
reaction mixture was allowed to warm to room temperature and stirred overnight. The aqueous 
liquors were washed with ether (2 x 600 ml), cooled in an ice-bath then acidified to pH 1.0 with 
conc. HC1. The aqueous solution was saturated with sodium chloride prior to extraction of the 
product into ethyl acetate (3 x 800 ml). The organic extracts were combined and dried (MgSO4) 
before removal of the solvent in vacuo to give a viscous golden syrup. 
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Crystallisation was observed on storage in a freezer under petrol at -20 °C producing the title 
compound as a white solid (125.15 g, 0.61 mol, 61%), m.p. 62-64 °C; [a]20 = -9.10 (c=1.12, 
MeOH); (Found: MIHt 206.06644 Caic. for C71112N06: MH, 206.06645); v max (CH2C12) 3600-
2600 (CO2H), 1745 (C=0), 1510 (amide II of urethane), 1380, 1250 and 1050 cm; oH/ppm 
(200MHz, DMSO-d6) 1.64 - 2.34 (4H,m,Glu 0- and y- CH2's), 3.50 (3H,s,-OCH3), 3.92 (1H,M,Glu 
a- CH), 7.38 (1H,brd, J=1OELz, -NH), 11.34 (2H,br s,-0O2H); ni/z(FAB) 206, 188, 160 and 142. 
a-Benzvl-N-methoxvcarbonvl-L-glutamate.dicvclohexvlamine salt 11401 (MOC-Glu(OH.DCHM-
OBzl) 
Triethylamine (143.6 ml, 1.03 mol) and benzyl bromide (125.9 ml, 1.06 mol) were added 
sequentially to a solution of MOC-Glu (210.97 g, 1.03 mol) in dry dimethylformamide (500 ml) at 0 
0C. The reaction mixture was allowed to warm to room temperature and stirred overnight. The 
reaction mixture was poured into iced water (1.5 dm3) and the resultant oil extracted into ethyl 
acetate (4 x 500 ml). The combined organic extracts were washed with water (2 x 500 ml), dried 
(MgSO4), and concentrated in vacuo to a volume of circa 800 ml. Ether (1.5 dm3) was added and 
the solution cooled to 0 °C before dicyclohexylamine (125.6 ml, 1.03 mol) was added dropwise 
over 45 minutes. Ether was added as necessary to keep the stirred mixture mobile as the salt 
precipitated out. The reaction mixture was left standing in a refrigerator overnight. The solids were 
collected by filtration, washed thoroughly with ether, dried and recrystallised from ether/ethanol to 
give the title compound as white crystals (289.8 g, 0.61 mol,59%), m.p. 154-155 °C; [a]20=  -16.8° 
(c=1.02,CHC13); (Found: MH,477.2964. Calc. for C26H41N206: MH,477.2964); (Found: 
C,65.3%; H,8.2%; N,6.1%. C261-140N206 requires C,65.5%; H,8.5%; N,5.9%); v max (CH2Cl2) 
2940(CH), 1730(C=O), 1630 and 1510 cm (amide II of urethane);dH/ppm (200MHz,CDC13) 1.05-
2.05 (22H,m,cyclohexyl H's), 2.20(2H,m,Glu f3-CH2), 2.80(2H,m,Glu y-CH2), 3.60(3H,s,-OCH3), 
4.20 (1H,m,Glu cc-CH), 5.10 (2H,s,benzyl CH2), 7.27 (5H,s,aromatic CH), 7.40 (114, br s,Glu NH), 
9.20 (2H,br s,-NB2); Oc4pm  (50MHz,CDC13) 24.40, 24.69, 28.58 (cyclohexyl C112's), 51.42 (-
OCH3), 52.01 (cyclohexyl CH's), 54.65 (Glu cx-CH), 66.15 (benzyl CH2), 127.51, 127.70, 128.02 
(aromatic CH's), 135.38 (aromatic quat.C), 156.60, 172.11, 177.96 (carbonyl C's); m/z(FAB) 477, 
461, 445, 387, 296, 272, 212 and 182. 
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a-Benzvl-N-methoxvcarbonvl-L-glutamate [1411 (MOC-Glu-OBzfl 
A solution of citric acid (111.37 g, 530 mmol) in water (500 ml) was added slowly to a rapidly 
stirred suspension of MOC-Glu(OH.DCHA)-OBzl (249.13 g, 523 mmol) in ethyl acetate (1.75 
dm3). The two-phase mixture was stirred vigorously for 3 hours. The layers were separated and the 
aqueous layer extracted with ethyl acetate (400 ml). The extract was combined with the organic 
layer then washed with water (800 ml) and brine (800 ml) before being dried (MgSO4). Removal of 
the solvent in vacuo gave a thick golden syrup which on trituration with petrol gave a white solid 
which was recrystallised from ethyl acetate/petrol to give the title compound as white crystals 
(152.05 g, 515 mmol, 98%), m.p.75-76 °C; [a]20 = -25.60 (c=0.71,MeOH); (Found: MH, 
296.11339. Cale. for C14H18N06: MH,296.11340); (Found: C,57.3%; H,6.1%; N,4.9%; 
C14H17N06 requires C,57.0%; H,5.8%; N,4.7%); v max (CH2C12) 3440 br (acid OH), 2960 (CH), 
1720 br (C=O), 1510 (amide II of urethane) and 1070 cm'; oH/ppm  (200MHz, CDC13) 1.93 -2.21 
(2H,m,Glu 3-CH2), 2.36 - 2.45 (2H,m,Glu 'y-CH2),3.64(3H,s,-OCH3), 4.43(1H,m,Glu CC-CH), 
5.1 5(2H,s,benzyl C112), 	5.64(1 H,bd,J=8.2 	Hz,Glu 	NH), 	7.33(5H,s,aromatic 	CH's), 
10.30(1H,bs,CO2H); OC/ppm  (50MHz, CDCI3) 27.09, 29.66 (Glu CH2's), 52.32 (CH3), 53.13 (Glu 
a-CR), 67.20 (benzyl CH2), 127.22, 127.41, 128.11, 128.35, 128.45 (aromatic CH's), 134.93 
(aromatic quat.C), 156.64, 171.71 and 177.55 (carbonyl C's): m/z (FAB) 296, 278, 250, 188 and 
160. 
cx-Benzyl-'y-terr-butyl-N-methpxycarbonyl-L-glutampte 11421 (MOC-Glu-(Qt-Bu)-OBzl 
Isobutene (circa 100 ml) was condensed into a conical flask cooled by a dry ice/acetone bath. The 
isobutylene was then poured quickly into a re-sealable bottle containing a solution of MOC-Glu-
OBzl (28.64 g, 97 mmol) in dry dichioromethane (250 ml) which had been cooled to -78 °C (dry 
ice/acetone). Concentrated sulphuric acid (2 ml) was added along with cuprous chloride (500 mg) 
and the bottle was sealed and allowed to warm to room temperature before standing, with 
occasional swirling, for 10 days. The reaction vessel was cooled to -78 °C then opened. Aqueous 
sodium carbonate (IM; 80m1) was added and the vessel allowed to attain room temperature then left 
overnight so that the excess isobutene would evaporate. The organic layer was separated and dried 
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(MgSO4) then the solvent was removed in vacuo. The residue was dissolved in ethyl acetate (250 
ml), washed with water (100 ml), and dried (MgSO4). Removal of the solvent in vacuo gave the 
title compound as a pale yellow oil which could not be crystallised (30.59 g, 87.1 mmol, 90%), 
[a]20 = -26.70 (c=0.24, Me011); (Found: MH, 352.17600); (Found: C, 61.9%; H, 7.6%; N, 3.8%. 
C18H25N06 requires C,61.5%; H, 7.2%; N, 4.0%); v max (CH2C12) 3430 (NH), 2980 (CH), 1730 
br (C=0) and 1510 (amide II of urethane) cm-1, 	/ppm (200MHz, CDC13) 1.37 (9H,s,t-butyl), 
1.90-2.07 (2H,m,Glu 13-CH2), 2.15-2.25 (2H,m,Glu T-CH2), 3.59 (3H,s,-OCH3), 4.36 (1H,m,Glu 
cc-CM, 5.11 (2H,s,benzyl CUD, 5.70 (1H,br d, J=8.3 Hz, -NH), 7.29 (5H,s,aromatic CH's); öc/ppm 
(50MHz, CDC13) 27.19, 31.08 (Glu 3- and yCH2'S),  27.72 (t-butyl CH31s), 52.00 (-OCH3), 53.26 
(Glu (x-CR), 66.87 (benzyl C142), 80.39 (t-butyl quat.C), 127.95, 128.13, 128.30 (aromatic CH's), 





Aqueous sodium hydroxide (1M; 370 ml, 370 mmol) was added dropwise to a stirred solution of 
MOC-Glu-(Ot-Bu)-OBzl (126.81 g, 361 mmol) in acetone (600 ml) during 20 minutes. The reaction 
mixture was stirred for a further 30 minutes before the acetone was removed in vacuo. The residual 
aqueous liquors were washed with ether (2 x 200 ml), cooled to 0 °C in an ice bath, then acidified to 
pH 4.0 with 1M HCL(aq). The aqueous solution was extracted with ethyl acetate (3 x 600 ml) and 
the combined extracts were washed with water (2 x 250 ml) and brine (300 ml) before being dried 
(MgSO4). Removal of the solvent in vacuo gave a golden syrup which crystallised on trituration 
with petrol to give the title compound as a white solid which was recrystallised from ethyl 
acetate/petrol (79.35 g, 304 mmol, 82%), m.p. 58 °C; [a]20  = -6.870 (c=1.21, MeOH); (Found: 
MH, 262.12904. Cale. for C11H20N06: MH,262.12905); Found: C,50.3%; 11,7.4%; N,5.6%. 
C111-119NO6 requires C, 50.6%; 11, 7.4%; N,5.4%); v max (CH2C12) 3430 (NH), 1725 br (C=0), 
1510 (amide II of urethane) and 1060 cm-1; 11/ppm (200MHz, CDC13) 1.41 (91-1,s,t-butyl), 1.92 - 
2.24 (2H,m,Glu -CH2), 2.27 - 2.39 (2H,m,Glu 'y-CH2), 3.65 (3F1,s,-OCI-13), 4.29 (IH,m,Glu a- 
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CH), 5.62 (1H,br d, J=8 Hz, Glu NH), 8.94 (1H, br s, CO2H); öc/ppm  (50MHz, CDC13) 27.06, 
30.98 (Glu - and 'y-CH2's), 27.72 (z-butyl CH3's), 52.29 (OCH3), 52.86 (Glu a-CH), 80.92 (t-butyl 
quat.C), 157.35, 172.41, 175.27 (C=O's); m/z (FAB) 262, 246, 188 and 160. 
METHOD B 
A solution of MOC-Glu-(Ot-Bu)-OBzl (2.153 g, 6.1 mmol) in 10% water-methanol (35 ml) was 
cooled to -78 °C (dry ice/acetone) and 10% palladium on charcoal (215.3 mg) was added slowly 
with gentle swirling of the flask. The reaction mixture was stirred vigorously under a hydrogen 
atmosphere at room temperature and atmospheric pressure for 12 hours. The black suspension was 
filtered through a 1cm pad of Celite and this was washed with methanol (20 ml). The filtrate and 
washings were combined then poured into aqueous sodium bicarbonate (1M; 80m1). The aqueous 
solution was extracted with ether (2 x SOmI), cooled in ice and acidified to pH 4.0 with 2M HC1(aq) 
before being extracted with ethyl acetate (3 x 50 ml). The combined extracts were washed with 
water (60 ml), brine (60 ml) and dried (MgSO4). Removal of the solvent in vacuo gave a golden 
syrup which crystallised on trituration with petrol to give a white solid which was recrystallised 
from ethyl acetate/petrol to afford the title compound as white crystals (1.190 g, 4.6 mmol, 75%), 
m.p. 57-58 °C; [a]20= -7.10 (c=0.62, MeOH); (Found: M1H, 262.12905. Calc. for C1 1H20N06: 
MH, 262.12905); (Found: C, 50.5%; H, 7.2%; N,5.2%. C11H19N06 requires C,50.6%; H,7.4%; 
N,5.4%); v max (CH2C12) 3430 (NH), 1725 br (C=0), 1510 (amide II of urethane) and 1060 cm-1; 
H/ppm (200MHz, CDC13) 1.39 (9H,s,t-butyl), 1.81-2.23 (2H,m,Glu -CH2),2.26 - 2.44 (2H,m,Glu 
y-CH2), 3.64 (3H,s,OCH3), 4.32 (1H,m,Glu (t-CH), 5.6 (1H,br d, J=7.1 Hz, NH), 9.3 (1H,br 
s,CO2H); m/z (FAB) 262, 246, 188 and 160. 
-rert-Butyl-N-methyl-N-methoxycarbonvl-L-glu tam ate, 
cyclohexylamine salt [1441 (MOC(Me-Glu-(Ot-Bu)-OH.CHA) 
Methyl iodide (distilled, 88.30 g, 0.62 mol) was added to a solution of MOC-Glu-(Ot-Bu)-OH 
(20.29 g, 77.7 mmol) in anhydrous tetrahydrofuran (200 ml) and this mixture was cooled in an ice 
bath and stirred rapidly. Sodium hydride (50% w/w in oil; 11.18 g, 233 mmol) was added in small 
portions (so as to avoid very rapid evolution of hydrogen) and the reaction was stirred at room 
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temperature under nitrogen for 6 days. Ethyl acetate (200 ml) and water (40 ml, carefully) were 
added to the stirred reaction mixture then the organic solvents were removed in vacuo. The aqueous 
residues were partitioned between water (300 ml) and ether (200 ml). The layers were separated, 
the ethereal layer being extracted with 5% w/v aqueous sodium bicarbonate (200 ml). The aqueous 
portions were combined, cooled in ice and acidified carefully to pH 3.0 with 2M HCl(a. The 
acidic liquors were immediately extracted with ethyl acetate (4 x 250 ml) and the combined extracts 
were washed with water (200 ml), 5% w/v aqueous sodium thiosulphate (2 x 300 ml), water (200 
ml) and brine (200 ml). The organics were dried (MgSO4) and concentrated in vacuo to give a 
golden syrup (7.776 g). 
The viscous syrup was dissolved in dry ether (35 ml) and the solution cooled in ice before 
cyclohexylamine (2.796 g, 28.2 mmol) was added dropwise. Petrol (45 ml) was added to the stirred 
reaction mixture, which was allowed to attain room temperature and stirred overnight for 16 hours. 
The white precipitate which had formed was collected by filtration then washed several times with 
dry ether. The resultant white solid was recrystallised from ethyl acetate/petrol to give the title 
compound as white crystals (5.912 g, 15.8 mmol, 20%), m.p. 109-111 °C; [a]20 = -16.80 (c=0.72, 
CHC13); (Found: MOC(Me)-Glu-(Ot-Bu)-0, 274.12876. Calc. for C12H20N06, MOC(Me)-Glu-
(Ot-Bu)-0, 274.12877); (Found: C,57.4%; H,9.2%; N,7.4%. C181-134N206 requires C,57.7%; 
H,9.1%; N,7.5%); v max (CH2Cl2) 2950 (CH), 1730 br (C=0) and 900 cm-1; H/ppm  (200MHz, 
CDC13) 1.07 - 1.31 (6H,m,cyclohexyl f3-and 'y-CH2's), 1.36 (9H,s,t-butyl), 1.54 - 1.91 
(6H,m,cyclohexyl (x-CH21s and Glu 3-CH2), 2.10 - 2.19 (2H,m,Glu y-CH2), [2.73, 2.74] (3H, split 
due to rotational isomerism, NCH3), 2.80 - 2.87 (1H,m,cyclohexyl CH), [3.58, 3.60] (3H, split due 
to rotational isomerism, OCH3), 4.30 - 4.33 (1H,m,Glu (x-CH), 7.75 (3H,br s,NH3); sc/ppm 
(50MHz, CDC13) [24.29, 24.66], [30.36, 30.86] (split due to rotational isomerism Glu - and y-
CH21s) 25.24, 25.66, 28.61 (cyclohexyl CH21s), 27.86 (t-butyl C1431s), 31.42 (Glu (x-CH), 49.92 
(cyclohexyl CH), 52.28 (OCH3), [60.20, 60.59] (split due to rotational isomerism NCH9, 79.84 (t- 
butyl quat.C), [157.39, 157.50] (split due to rotational isomerism MOC C=0), 172.28, 176.40 




A solution of citric acid (2.749 g,13 mmol) in water (30 ml) was added dropwise to a rapidly stirred 
slurry of MOC(Me)-Glu-(Ot-Bu)-OH.CHA (4.417 g, 11.8 mmol) in ethyl acetate (80 ml) and the 
biphasic mixture was stirred for 3 hours at room temperature. The layers were separated, the 
aqueous liquors being extracted with ethyl acetate (50m1). The organics were combined then 
washed with water (2 x 100 ml), brine (100 ml) and dried (MgSO4). The solvent was removed in 
vacuo and the resultant golden syrup was triturated with petrol to induce solidification. The solid 
was recrystallised from ether/petrol to give the title compound as white crystals (3.067 g, 11.1 
mmol, 94%), m.p. 69-71 °C; [a]20  = -24.20 (c=0.98,CHC13); (Found: Mff,276.14471. CaIc. for 
C12H22N06: MH, 276.14470): (Found: C, 52.2%; H, 7.7%; N, 5.1%. C12H21N06 requires C, 
52.4%; H, 7.7%; N, 5.1%); v max (CH2Cl2) 3500 - 2800 br (CO21-1), 2980 (CH), 1730 br (C=0), 
1510 (amide II of urethane), 1065 and 850 cm* H/ppm (200MIHz, CDCI3) 1.38 (9H,s,t-butyl), 
1.90 - 2.07 (2H,m,Glu f3-CH2), 2.17 - 2.24 (2H,m,Glu ?-CH2), [2.76, 2.79] (31-1, split due to 
rotational isomerism, NCH3), [3.59, 3.62] (3H, split due to rotational isomerism, OCH3), 4.53 - 
4.72 (1H,m,GIu (x-CR), 10.22 (11-1, br s, CO2H); sc/ppm  (50MHz, CDC13) [23.52, 23.75], (31.33, 
31.74] (split due to rotational isomerism, Glu 0- and y-CH21s), 27.74 (t-butyl CR3Ts), [30.67, 30.95] 
(split due to rotational isomerism, Glu a-CH), 52.95 (OCH3), [57.59, 57.89] (split due to rotational 
isomerism, NCH3), 80.63 (t-butyl quat.C), [156.79, 156.93], [171.74, 171.90], 175.02, 175.51] [split 
due to rotational isomerism, C=O's); m/z (FAB) 276, 262, 220, 206 and 174. 
(S)-4-[2'(tert-Butyloxycarbonyl)ethyl-3 -methvloxazolidine-2.5-dione [1331 
MOC(Me)-Glu-(Ot-Bu)-OH (1.034 g, 3.76 mmol) was dissolved in freshly distilled thionyl chloride 
(6 ml) and the solution was stirred at 0 °C for 15 minutes before a pressure of circa 5 mm Hg was 
applied to the reaction vessel. The evacuated flask was warmed to 55 °C for 25 minutes then cooled 
to room temperature once all the volatile material had been removed. The flask was returned to 
atmospheric pressure and the residue dissolved in carbon tetrachloride (15 ml) then the solvent was 
removed in vacuo. The brown residue crystallised spontaneously and recrystallisation from dry 
ether/petrol gave the title compound as white crystals (713 mg, 2.93 mmol, 78%), m.p. 81-82 °C; 
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[a]20  = -51.60 (c=1.16, CHCI3); (Found: C,54.0; H,6.9%;N,5.7%. C11H17N05 requires C,54.3%; 
H,7.0%; N,5.8%); v max (CH202) 2980 (CH), 1850, 1785, 1725 (cyclic anhydride and ester 
C=O's), 1155 and 975 cm; H/pPm  (200MHz, COd3) 1.44 (9H,s,t-butyl), 2.02 - 2.29 (2H,m,1'-
CH2), 2.32 - 2.43 (2H,m,2'-CH2), 2.99 (3H,s,NCH3), 4.20 - 4.25 (1H,m,4-H); öc/ppm  (50MHz, 
CDC13), 23.69, 29.09 (C1121s), 28.41 (4-C), 59.96 (NCH3), 81.21 (t-butyl quat.C), 151.66, 168.29, 
170.82 (C=O's); m/z (FAB) 236, 218, 174 and 162. 
Methyl 3-methylisoxazole-5-acetate 11481 
METHOD A 
The required compound, prepared by the method of Micetich1 12,  was obtained as a clear colourless 
liquid (11.34 g, 73 mmol, 86%), b.p. 70 °C/0.5 mm Hg (lit. 112, 67 °C/0.2 mm Hg); (Found: MH, 
156.16263. Caic. for C7H10NO3: MH, 156.16264); (Found: C,53.9%; H,5.6%; N,8.9%. 
C7H9NO3 requires C,54.2%; H,5.8%; N,9.0%); v max (CH2C12) 2960 (CH), 1740 (C=0), 1610 
(aromatic), 1440 and 1020 cm4; H/ppm  (80MHz, CDCI3) 2.19 (3H,s,3-CH3), 3.65 (3H,s,OCH3), 
3.70 (2H,s,CH2), 6.02 (1H,s,4-H); m/z (FAB) 156, 115, 97, 83 and 69. 
METHOD B 
A solution of 3,5-dimethylisoxazole (29.133 g00 mmol) in dry tetrahydrofuran (300 ml) was 
cooled to -78 °C (dry-ice/acetone) under an argon atmosphere. n-Butyllithium (1.6M in hexanes; 
187.5 ml, 300 mmol) was added slowly through a double-ended needle and the resultant yellow 
solution stirred for 30 minutes before dry carbon dioxide gas was passed through the reaction 
mixture at a steady rate for 2 hours whilst the flask returned to room temperature. The solvent was 
removed in vacuo and the residual yellow solid was dissolved in water (500 ml). The aqueous 
solution was extracted with ether (2 x 250 ml), cooled in ice, and acidified carefully to pH 1.5 with 
2M HCI (aq) before being extracted with ethyl acetate (4 x 200 ml). The extracts were dried 
(MgSO4) then the solvent was removed in vacuo to give a brown solid which was dissolved in 50% 
methanol/water (60 ml). This solution was titrated to pH 7 with 20% w/w aqueous caesium 
carbonate. The solvents were then removed in vacuo leaving a thick brown sludge from which a 
precipitate formed upon the addition of dimethylformamide. A solid was obtained on removal of 
the solvent in high vacuo and the caesium salt was partially dissolved in dry dimethylformamide 
(100 ml) then methyl iodide (37.3 ml, 85.16 g, 0.6 mol) was 	added to the stirred slurry. 
Complete dissolution of the solids occurred after 5 minutes and, after 10 minutes, a white 
precipitate (CsI) had formed. The reaction was stirred for 2 hours then the solvent was removed in 
vacuo at 50 °C to leave a brown residue which was partitioned between water (600m1) and ethyl 
acetate (300 ml). The aqueous layer was extracted with ethyl acetate (2x250m1) and the combined 
organic portions were dried (MgSO4) and concentrated in vacuo to give a brown liquid which 
u)a 
/distilled to yield the required compound as a clear colourless liquid (38.63 g, 249 mmol, 83%), 
b.p.69-71% °C/0.5 mm Hg (lit.112, 67 °C/0.2 mm Hg); (Found: MH, 156.16263. CaIc for 
C7H10NO3: MH, 156.16264); (Found: C,54.1%; H,5.5%; N,8.8%. C7,119NO3 requires C,54.2%; 
H,5.8%; N,9.0%); v max (CH2C12) 2960 (CH), 1740 (C=0), 1610 (aromatic), 1440 and 1020 cm-1; 
H/ppm (200MHz, CDCI3) 2.14 (3H,s,3-CH3), 3.61 (3H,s,OCH3), 3.66 (2H,s,CH2), 5.99 (1H,s,4-
11); öC/ppm  (50MHz, CDCI3) 10.91 (3-CH3), 32.03 (CH2), 52.07 (OCR3), 103.70 (4-C), 159.60, 
164.43 (3-C and 5-C), 167.76 (C=0); mfz (FAB) 156, 115, 97, 83 and 69. 
(5S-5-[2'-(tert-Butyloxycarbonyl)ethyl] -1 -methyl-3-15'-(3 '-methyIisoxazole1tetramic acid 11201 
Lithium diisopropylamide (1.5M in cyclohexane; 5.35 ml, 8 mmol) was stirred in dry 
tetrahydrofuran (35 ml) under argon and this solution was cooled to -780 (dry ice/acetone). A 
solution of methyl 3-methylisoxazole-5-acetate (1.24 g,8 mmol) in dry tetrahydrofuran (15 ml) was 
added dropwise followed by N,N;N',N- tetramethylethylenediamine (1.21 ml, 929 mg,8 mmol) the 
resultant yellow reaction mixture being stirred for 30 minutes. 	(4S)-4-[2'-(tert- 
Butyloxycarbonyl)ethyl]-3-methyloxazolidine-2,5-dione (1.06 g, 4 mmol) was dissolved in dry 
tetrahydrofuran (10 ml) and this solution was added dropwise to the reaction mixture which 
subsequently was stirred for a further 4 hours at -78 °C and then allowed to warm to room 
temperature during a further 2 hour period. Removal of the solvents in vacuo gave a pale yellow 
gum which was partioned between ether (50 ml) and water (50 ml). The layers were separated, the 
aqueous being extracted with ether (50m1) before it was cooled in ice and carefully acidified to pH 
1.0 with 2M HCI(aq). A precipitate formed on standing and this was filtered off, washed quickly 
with ether (15 ml) and dried in vacuo overnight to afford the title compound as white crystals (670 
81 
mg, 2.08 mmol, 52%), m.p. 153-154 °C; [a]20  = 69.40 (c=0.17, MeOH); (Found: MH+, 
323.16066. Caic. for C16H23N205: MH, 323.16068); (Found: C,59.2%; H,7.1%; N,8.5%. 
C16H22N205 requires C,59.6%; 11,6.9%; N,8.7%); ?. max (CH3CN) 243 nm (c 11600), 272 nm (F-
14300), 
c
, X max (CH3CN + 1 drop 1M NaOH(aq)) 218 nm (e 7400), 272 nm (e 17650), 303 nm (c 
19950); v max (CH2C12) 2980 (CH), 1715, 1690 (ester and amide C=O's), 1610 (aromatic) and 1150 
cm'; 811/ppm (200MHz, CDC13) 1.40 (9F1,s,t-butyl), 2.12 - 2.28 (411,m,CH2's), 2.34 (3H,s,3"-
CH3), 2.95 (3H,s,NCH3), 4.05 - 4.08 (1H,m,5-H), 6.66 (1H,s,isoxazole 4"-H); sc/ppm  (50MHz, 
CDC13) 11.05 (3"-CH3), 23.38, 28.49 (CH2's), 26.65 (5-C), 27.92 (t-butyl CH31s), 60.34 (NCH3), 
80.74 (t-butyl quat.C), 97.00 (3-C), 100.61 (4"-C), 159.83, 162.45 (3"- and 5"-C'), 168.06, 169.78, 
171.92 (4-C and C=O's); m/z (FAB) 645, 323, 267 and 98. 
Ethyl fE-4-methylpent-2-enoate 11541 
Freshly distilled isobutyraldehyde (72.11 g, 1 mol) was added to a solution of 
carboethoxymethylidinetriphenyiphosphorane (279.31 g, 0.8 mol) in dry dichloromethane (500 ml). 
The reaction mixture was stirred for 18 hours overnight then concentrated in vacuo to a volume of 
circa 200 ml. The liquors were diluted with petrol (600 ml) and the precipitated triphenyiphosphine 
oxide filtered off and this process was repeated until removal of the solvent in vacuo gave a yellow 
liquid. Distillation of this crude product through a 15 cm Vigreux column gave the title compound 
as a clear, colourless liquid (84.18g, 0.59 mol, 74%), b.p. 55 °C/15mmHg; t.l.c.(A) Rf = 0.6; 
(Found: M, 142.09937. CaIc. for C8H1402: M, 142.09958); X max (CH3CN) 207 nm (c 14700); 
v max (CH2C12) 2980 (CH), 1730 (C=O), 1660 (C=C), 1045 and 870 cm; H/ppm 
(200MHz,CDC13) 1.06(6H,d,J=6.7Hz, 4-CH3's), 1.24 (3H,t,J=7.2 Hz, ester CH3), 2.40 (1H,m,4-H), 
4.09 (2H,q, J=7.2 Hz, ester CH2), 5.74 (1H,dd, J=1.2,15.7 Hz, 2-H), 6.92 (1H,dd, J=6.7,15.7 Hz, 3-
1:1); sc/ppm  (50MHz, CDC13) 14.11 (ester CH3), 21.01 (4-CH3's), 59.95 (ester CH2), 118.39, 
155.16 (C-2, C-3), 166.81 (C=O); m/z (El) 142, 114, 99, 97, 81 and 69. 
(E)-4-Methvlpcnt-2-en- 1-01 [155] 
Diisobutylaluminium hydride (1M in dichloromethane; 500 ml, 0.5 mol) was added slowly (via 
cannula ) to a solution of ethyl.(E)-4-methylpent-2-enoate (28.44 g, 0.2 mol) in dry 
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dichloromethane (100 ml) under an atmosphere of argon and maintained at a temperature of -78 °C 
(dry ice/acetone). The reaction was stirred at this temperature for 3 hours then 2M HCI(aq) (200 ml) 
was added very slowly over a period of 1 hour and the mixture was allowed to attain room 
temperature overnight. The layers were separated, the organic layer being washed with brine (300 
ml) then dried (MgSO4) and concentrated in vacuo to leave an oil. The oil was distilled to give the 
required compound as a clear, colourless liquid (18.23 g, 182 mmol, 91 %);  b.p. 67 °C/18 mm Hg 
(lit.135, 65 °C/20 mm Hg); (Found: M, 100.08885. Calc. for C6H120: M, 100.08881);v max 
(CH2C12) 3350 br (OH), 2980 (CH), 1660 (C=C), 1460 and 970 cm-1; oH/ppm  (200MHz, CDC13) 
0.93 (6H,d,J=7 Hz, 4-CH3's), 2.25 (1H,m,4-H), 2.45 (1H,br s,exc. D20, OH), 3.99 (2H,m,1-CH2), 
5.53 (2H,m,2-H and 3-H); OC/ppm  (50MHz, CDC13) 21.95 (4-CH3's), 30.40 (4-C), 63.29 (1-C), 
125.71, 139.71 (2-C and 3-C); m/z (El) 100, 93, 69, 57 and 32. 
(2S. 3S) 2.3-Enoxy-4-methylpentan- 1-01 [1571 
An oven dried flask was filled with argon and charged with anhydrous dichloromethane (500 ml), 
powdered 4A molecular sieves (2.60 g) then cooled to -23 °C (dry ice/CCI4). Titanium 
tetraisopropoxide (3.87 ml, 13 mmol) and L-(+)-diethy.artrate (3.48 g, 16.9 mmol) in anhydrous 
dichloromethane (20 ml) were added via syringe and the mixture stirred for 10 minutes before the 
addition of(E)-4-methylpent-2-en-1-ol (13.00 g, 130 mmol) in anhydrous dichloromethane (15 ml). 
The mixture was stirred for 30 minutes to allow the catalyst to form and then age, before a solution 
of terr-butylhydroperoxide (2.74M in isooctane, anhydrous, freshly prepared according to the 
method of Sharpless120; 71.2 ml, 195 mmol) was added via double-ended needle at such a rate that 
no temperature increase in the reaction flask occurred. The reaction was stirred at -23 °C for 2 
hours then stored in a freezer at -20 °C for 24 hours. The flask was cooled to -23 °C (dry ice/CC14) 
then dimethylkulphide  (38 ml, 0.52 mot) was added via syringe and the mixture stirred for 1 hour. 
The cold (circa 00)  reaction mixture was then poured into a saturated aqueous solution of sodium 
fluoride (108 g in 1.2 dm3 H20) and the two-phase system was stirred for 24 hours at room 
temperature. Sodium chloride (75 g) was added to saturate the aqueous layer and the two-phase 
mixture was filtered through a 1 cm Ce Site pad. The layers were separated, the aqueous being 
extracted with dichloromethane (3 x 400 ml) and the combined organic liquors were dried 
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(Na2SO4). Removal of the solvent in vacuo gave 18.661 g of crude product containing 
dimethylkulphoxide and L-(+)-diethyl tartrate. Kugelrohr distillation (b.p. 95 °C/18 mm Hg) gave a 
mixture of the epoxide and dimethyulphoxide which was purified by flash column chromatography 
(SiO2/ether) to give the title compound as a clear colourless liquid (10.52 g, 90.5 mmol, 70%); 
b.p.95 °C/18 mm Hg; t.l.c.(A) Rf = 0.30; [a]20 = -34.80 (c=1.02, CHC13); (Found: MB, 
117.09154. Caic. for C61-11302: MB, 117.09155); (Found): C,61.8%; H,10.2%. C6111202 
requires C,62.0%; H,10.4%); v max (CH2C12) 3420br (OH), 2980 (CH), 1460 (OH bend), 1065 and 
895 cm; /ppm (200MHz, CDC13) 0.92 (3H,d,J=7.0 Hz,CH3), 0.97 (3H,d,J=7.0 Hz,CH3), 1.50 
(111,m,4-11), 2.69 (1H,d of d,J=2.5,7.0 Hz,3-H), 2.80 (1H,br s,OH), 2.93 (1H,m,2-H), 3.46 - 3.89 
(2H,ABX,J=5.0,15.0 Rz,CH2); SC/ppm  (50MHz,CDCI3) 18.12, 18.77 (4-CH3's), 29.85 (4-C), 57.58 
(3-C), 61.09 (2-C), 61.83 (CH2); m/z (FAB) 117,99,79 and 58. 
(2R.3S)-2.4-Dimethvlpentan-1 .3-diol FJ.fil 
Copper(Idide (which had been extracted with tetrahydrofuran in a Soxhlet apparatus then dried 
thoroughly in vacuo at 100 °C; 74.10 g, 390 mmol) was suspended in anhydrous ether (400 ml) 
under argon and the magnetically stirred slurry was cooled to -45 °C (dry ice/MeCN). 
Methyllithium (1.4M in ether; 537 ml, 780 mmol) was added slowly (double-ended needle) to the 
suspension. A yellow colour was observed immediately, then the mixture was stirred for 30 minutes 
at -45 °C before the addition of (2S,3S)-2,3,-epoxy-4-methylpentan-1-ol (6.00 g, 51.6 mmol) in 
anhydrous ether (60 ml) over 15 minutes. The reaction mixture was stirred at -45 °C and quenched 
by the careful addition of a mixture of saturated aqueous ammonium chloride (270 ml) and 
concentrated aqueous ammonia solution (30 ml) over a period of 1 hour then allowed to warm to 
room temperature over a further 1 hour. The layers were separated, the aqueous being extracted 
with ether (3 x 500 ml), and the combined organic liquors were washed with brine (750 ml) then 
dried (MgSO4). The solvent was removed in vacuo to afford 5.992 g of a yellow oil which was 
purified by flash column chromatography (SiO2/ether) to give the title compound as a cream 
coloured waxy solid (5.592 g, 42.3 mmol, 82%), m.p. 50-52 °C; t.l.c. (A) Rf = 0.2; [a]20 = -20.80 
(c=1.40, CHC13); (Found:  MH, 133.12285. CaIc. for C71-11702: MIH, 133.12285); (Found: 
C,63.5%; H,12.2%. C7H1602 requires C,63.6%;H,12.2%); v max (CH202) 3420 br (OH), 2960 
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(CH) and 1070 cm; H/ppm  (200MHz, CDC13) 0.83 (3H,d,J=7.0 Hz,4-CH3), 0.89 (3H,d,J=7.0 
Hz,4-CH3), 0.93 (3H,d,J=7.0 Hz, 3-CH3), 1.79 (2H,m,2-H,4-H), 3.28 (1H,d of d,J=z4.0,7.0 Hz,3-H), 
3.56 - 3.71 (2H,AB q,CH2). 3.80 (21-1, br s, OH'S); SC/ppm  (50MIHz,CDC13) 13.69, 14.84 (4-
CH31s), 19.69 (2-CR3), 30.10 (4-C), 36.88 (2-C), 67.75 (CR2), 81.61 (3-C); m/z (FAB) 133, 117, 
103, 97 and 75. 
(2R.3S)-3-Hvdroxv-2.4-dimethvlpentyl benzoate [1631 
Distilled benzoyl chloride (2.33 g,16.6 mmol) in dry pyridine (30 ml) was added to a solution of 
(2R,3S)-2,4-dimethylpentan-1,3-diol (2.00 g, 15.1 mmol) in dry pyridine (40 ml) which had been 
cooled in ice. The mixture was stirred at room temperature for 18 hours overnight under a nitrogen 
atmosphere then the cloudy suspension was poured into cold 10% HC1(aq) (1 dm3) and shaken with 
ether (600 ml). The layers were separated and the aqueous extracted with ether (3 x 100 ml) and 
the combined organics were washed with brine (150 ml) then dried (MgSO4). The solvent was 
removed in vacuo to afford 3.795 g of a yellow oil which was purified by dry flash chromatography 
(Si02/petrol - 50% ether/petrol gradient) to give the title compound as a clear colourless liquid 
(2.916 g,12.3 mmol,81%), b.p. 120 °C/1.0 mm Hg; t.l.c. (C) Rf = 0.4; [a]20  = +8.30 
(c=1.52,CHCI3); (Found: MH, 237.14905. CaIc. for C141-12103: MH=237.14906); Found: 
C,70.9%; 1-1,8.3%. C14H2003 requires C,71.2%; H,8.5%; v max (CH2C12) 3480 br (OH), 3070 
(aromatic CH), 2960 (CH), 1710 (0=0), 1605 (aromatic C=C) and 710 cm'; H/ppm  (200MHz, 
CDC13) 0.87 - 1.04 (91-1, 3 x d, J=6.7 Hz, 3-CH3 and 4-CH3'S), 1.79 - 1.88 (1H,m,4-H), 2.00 - 2.12 
(1H,m,2-H), 2.36 (1H,br s,OH), 3.22 - 3.28 (1H,d of d,J=4.2, 7.8 Hz, 3-H), 4.44 (2H,d,J=5.2 Hz, 
CR2), 7.34 - 7.56 (3H,m,Hb  and Hc of aromatic), 7.99 - 8.06 (2H,m,Ha  of aromatic); SC/ppm 
(50MHz, CDC13) 14.32, 15.12 (4-CH3's), 19.96 (2-CR3), 29.71 (4-C), 36.13 (2-C), 67.17 (CR2), 
77.50 (3-C), 128.19, 129.35, 132.75 (aromatic CH's), 130.07 (aromatic quat.C), 166.78 (0=0); m/z 
(FAB) 237, 219, 202, 181 and 165. 
(2R.3S)-3-(tert-ButyldimethyIsiIyloxy-2.4-dimethylpentyl benzoate [1641 
Imidazole (recrystallised; 3.349 g, 49.2 mmol), tert-butyldirnethylsilyl chloride (3.708 g, 24.6 
mmol) and 4-'äimethylamino"pyridine (150 mg, 1.2 mmol) were dissolved in dry 
dimethylformarnide (10 ml) then a solution of (2R,3S)-3-hydroxy-2,4-dimethylpentyl benzoate 
(2.916 g, 12.3 mmol) in dry dimethylformamide (10 ml) was added to the mixture. The reaction 
mixture was stirred at 45 °C under nitrogen for 5 days, cooled to room temperature, diluted with 
water (60 ml) and extracted with petrol (5 x 50 ml). The combined organic extracts were washed in 
brine (50 ml) and dried (MgSO4) then concentrated in vacuo to give 5.760 g of a yellow liquid 
which was purified by dry flash chromatography (Si02/10% ether-petrol) to give the title compound 
as a clear colourless liquid (4.032 g,11.5 mmol,93%), b.p. 143 °C/15 mm Hg; t.l.c. (E) Rf = 0.35; 
[a]20 = +15.40 (c=1.16,CHC13); (Found: MIH,351.58614. 	Caic. for C20H3503Si: 
MH,351.58615); v max (CH2C12) 3040 (aromatic CH), 2980 (CH), 1725 (C=O), 1605 (aromatic 
C=C), 1390 and 710 cm; oH/ppm  (200MHz,CDC13) [0.03, 0.05] (6H, split due to 
diastereotopicity, Si CH31s), 0.85 - 0.89 (6H,2 x d,J=7.0 Hz, 4-CH3s), 0.91 (9H,s,t-butyl), 0.96 
(3H,d,J=7.0 Hz, 2-CH3), 1.75 - 1.90 (1H,m,4-H) 1.94 - 2.17 (1H,m,2-H), 3.40 - 3.46 (1H,d of d, 
3=4.2, 5.0 Hz, 3-H), 3.96 - 4.48 (2H,ABX,CH2), 7.24 - 7.51 (3H,m,Hb  and Hc of aromatic), 7.97 - 
8.09 (2H,m,Ha  of aromatic); 5C (50MHz,CDC13) -4.10 (Si-CH315), 18.52 (t-butyl CH3's), 29.86 (4-
C), 36.36 (2-C), 66.87 (CH2), 78.02 (3-C), 127.91, 128.75, 132.43 (aromatic CH's), 131.18 
(aromatic quat.C), 167.62 (C=0); m/z (FAB) 351, 293, 187, 185, 179, 105 and 97. 
(2R.3S)-3-(tert-Butyldimethylsilylpxy)-2.4-dimethylpentan- 1 -01 {151 
A solution of (2R,3S)-3-(tert-butyldimethylsilyloxyl-2,4-dimethylpentyl benzoate (4.032 g,11.5 
mmol) and potassium hydroxide (1.24 g,22.1 mmol) in dry methanol (50 ml) was stirred under 
nitrogen at 40 °C for 16 hours overnight. The solvent was removed in vacuo and the residue 
partitioned between ether (100 ml) and saturated aqueous ammonium chloride (100 ml). The layers 
were separated, the aqueous being extracted with ether (2 x 60 ml) and the combined organic liquors 
were washed with brine (100 ml) and dried (MgSO4). The solvent was removed in vacuo to give 
3.097 g of a yellow oil which was purified by flash-column chromatography (Si02/10% ether- 
petrol) to afford the title compound as a clear colourless oil (2.687 g, 10.9 mmol, 95%), b.p. 110 
°C/18 mm Hg; [a]20 = +6.60 (c=0.95, CHCI3); (Found: MH, 247.20934. Calc. for C13H3102Si: 
MH, 247.20932); (Found: C,63.2%; H,12.1%. C13H3002Si requires C,63.3%; H,12.3%); V max 
(CH2C12) 3350 br (OH), 2960 (CH), 1460, 1250 and 770 cm; OH/ppm  (200MHz, CDCI3) [0.07 - 
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0.101 (6H, split due to diastereotopicity), 0.89 (3H,d,J=7.0 Hz, 4-CH3), 0.91 (9H,s,t-butyl), 0.94 
(3H,d,J=7.0 Hz, 4-CH3), 0.98 (3H,d,J=7.0 Hz, 2-Cl3), 1.80-1.85 (21, overlapping multiplet, 2-H 
and 4-H), 2.61 (1H,br s,OH), 3.41 (1H,t,J=5.0 Hz,3-H), 3.57-3.63 (2H, ABX, CH2); SC/ppm 
(50MHz, CDC13) -4.07 (Si-CH31s), 16.20, 18.21 (4-CH3's), 18.97 (2-CH3), 26.04 (t-butyl CH3's), 
33.01 (4-C), 37.50 (2-C), 65.90 (CH2), 77.54 (t-butyl quat.C), 82.00 (3-C), m/z (FAB) 247, 229, 
217,203, 187, 133, 115 and 97. 
(2R.3S)-3-(tert-Butvldimethylsilyloxv)-2.4-dimethylpentanal [1661 
(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2,4-dimethylpentan-1-ol (1.179 g, 4.9 mmol) and N - 
methylmorpholine IV-oxide (844 mg, 7.2 mmol) were dissolved in dry dichioromethane (20 ml) 
containing powdered 4A molecular sieves (500 mg). Tetra-n-propylammonium per-ruthenate (8.4 
mg, 24.0 lImo!) was added and the mixture stirred under nitrogen for 16 hours overnight after which 
the reaction was diluted to a volume of 50 ml with dichioromethane. The solution was washed with 
aqueous sodium sulphite (50 ml), brine (50 ml) and aqueous copper sulphate (50 ml) then dried 
(MgSO4). Removal of the solvent in vacuo gave 1.286 g of a yellow oil which was purified by dry-
flash chromatography (Si02/10% ether-petrol) to give the title compound as a clear colourless oil 
(954 mg, 3.9 mmol, 81%) Ll.c. (E) Rf = 0.86; [a]20 = +32.40 (c=0.99, CHCI3); (Found: MH+, 
244.45289. Cale. for C13H2802Si: MH+, 244.45291); v max (CH2C12) 2960, 2710 (CI), 1710 
(C=0), 1460, 1360, 1220 and 840 cm'; H/ppm  (200MHz, CDC13) [0.03, 0.05] (6H, split due to 
diastereotopicity, Si-CH3's), 0.81 - 1.03 (15H,m,Si t-butyl CH3s, 4-CH3's), 1.09 (3H,d,J=7.0 Hz, 
2-CH3), 1.85 (1H,m,4-H), 2.49 (1H,m,2-H), 3.62 (1H, overlapping d of d, 3-H), 9.72 (1H,d,J=3.0 
Hz, CHO); SC/ppm  (50MHz, CDC13)  [-4.47, -4.30] (split due to diastereotopicity, Si-CH3'S), 14.57, 
18.62 (4-CH3s), 19.23 (2-CH3), 25.47 (t-butyl CH3's), 32.61 (4-C), 49.70 (2-C), 77.56 (t-butyl 
quat.C), 79.97 (3-C), 204.61 (C=0); m/z (FAB) 244,202, 187, 143, 129, 117 and 75. 
Carbomethoxvethvlidinetriphenvlphosphorane [1701 
Methyl-2-bromopropionate (100.10 g, 0.6 mol) was added to a solution of triphenylphosphine (78.60 
g, 0.3 mol) in dry toluene (200 ml) and the stirred mixture was warmed to 50 °C and stirred for 18 
hours. The mixture was allowed to cool to room temperature during 1 hour and the white solid was 
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collected by filtration and washed with ether (3 x 100 ml) then dried in a vacuum oven at 40 °C. 
The phosphonium salt was then dissolved in dichloromethane (500 ml) and the solution cooled in 
ice before aqueous sodium hydroxide (1M) was added dropwise until the phenolphthalein indicator 
remained pink. The layers were separated immediately, the aqueous layer being extracted with 
dichloromethane (2 x 150 ml), and the combined organic liquors were dried (MgSO4). Removal of 
the solvent in vacuo gave a yellow solid which was recrystallised from 50% ethyl acetate-petrol to 
yield the required compound as fine yellow crystals (89.38 g, 256 mmol, 85%), m.p. 149-151 °C 
(lit.124, m.p. 152-153 °C); (Found: MH+, 349.13575. CaIc. for C22H2202P: MH+, 349.13578); 
(Found: C,75.7%; H,5.9%. C22112102P requires C, 75.8%; H,6.1%; v max (CH2Cl2) 3040 
(aromatic CH), 2980 (CH), 1700 (C=0), 1315, 1100 and 1000 cm-1; H/ppm  (200MHz, CDC13) 
1.50-1.68 (3H,d,J=14.0 Hz, P-C-CH3), 3.30 (3H,s, OCH3), 7.37-7.73 (15H,m,aromatic CH's); m/z 
(FAB) 349, 333, 317, 289,252, 183 and 165. 
Methyl (2E:4R.5S)-5-(tert-Butyldimethylsilyloxy)-2.4 ,6-trimethvlhept-2-enoate 1171 
Carbomethoxyethylidinetriphenylphosphorane (2.037 g,5.85 mmol) was added to a solution of 
(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2,4-dimethylpentanal (954 mg, 3.9 mmol) in dry benzene 
(25m1) and the resulting yellow solution was refluxed under nitrogen for 5 days. The reaction 
volume was reducedn vacuo to circa 10 ml then diluted with petrol (30 ml). The white precipitate 
was filtered off, washed with petrol (50 ml), and the combined filtrate and washings were 
evaporated in vacuo to leave a yellow oil. This was purified by dry-flash chromatography 
(Si02/10% ether-petrol) to give the title compound as a clear colourless oil (968 mg, 3.08 mmol, 
79%), t.l.c. (D) Rf = 0.40; [a]20  = +7.60 (c=1.02, CHC13); (Found: MH+, 315.23506. Calc. for 
C17H3503Si: M11+, 315.23507); ? max (CH3CN) 225 nm (e 6400); v max (CH2C12) 2960 (CH), 
1710 (C=0), 1460, 1240 and 840 cm-1; H/ppm  (200MHz, CDC13) [0.01,0.03] (6H, split due to 
diastereotopicity, Si-CH3's), 0.80 - 0.87 (6H, overlapping pair of doublets, 6-CH3s), 0.91 (9H,s,t-
butyl), 0.95 (3H,cl,J=7.0 Hz, 4-CH3), 1.65 - 1.80 (1H,m,6-H), 1.84 (3H,s,2-CH3), 2.59 - 2.72 
(1H,m,4-H), 3.33 - 3.36 (1H, overlapping d of d, 5-H), 3.69 (3H,s, OCH3), 6.81 (1H,d,J=10.0 Hz, 3-
H); 5C/pp' (50MHz, CDC13)  4.01 (Si-CH3S), 12.30, 17.81, 18.24, 19.35 (6-CH31s, 4-CH3 and 3-
CH3), 25.98 (Si t-butyl CH3's), 32.48 (6-C), 36.64 (4-C), 51.41 (OCH3), 77.12 (t-butyl quat.C), 
80.42 (5-C), 125.71 (2-C), 145.57 (3-C), 168.77 (C=O); m/z (FAB) 315, 300, 280, 263, 243, 183, 
147 and 133. 
(2E:4R.5S)-5-(terr-ButvIdimethvlsilv1oxy-2.4.6-trimcthylhept-2-en-I-pl 11781 
Diisobutylaluminium hydride (1M in dichloromethane; 13.25 ml, 13.25 mmol) was added to a 
solution of methyl (2E;4R,5S)-5-(tert-butyldimethylsilyloxy)-2,4,6-trimethylhept-2-enoate (1.681 g, 
5.3 mmol) in dry dichloromethane (30 ml) which had been cooled to -78 °C (dry ice/acetone) under 
an argon atmosphere. The reaction mixture was stirred for 3 hours at 780C  before the reaction was 
quenched by the careful addition of water (5 ml) then allowed to warm to room temperature during 
30 minutes. The mixture was transferred to a separating funnel containing saturated sodium 
potassium tartrate (250 ml) and dichloromethane (200 ml), shaken, then the layers were separated 
and the aqueous extracted with dichloromethane (4 x 300 ml). The combined organic liquors were 
dried (MgSO4) and concentrated in vacuo to give 1.336 g of a yellow oil. This was purified by dry-
flash chromatography (Si02/petrol - 30% ether-petrol gradient) to give the title compound as a clear 
colourless liquid (1.048 g, 3.66 mmol, 69%), t.l.c.(B) Rf = 0.38; [a]20 = +4.70 (c=0.81, CHC13); 
(Found: MH+, 287.22450. CaIc. for C16H3502Si: MH+, 287.22452); (Found: C,66.8%; H,12.2%. 
C16H3402Si requires C,67.1%; H,12.0%); v max (CH2C12) 3600 (OH), 2980 (CH), 1665 (C=C), 
1460, 1050 and 840 cm'; H/ppm  (200MHz, CDCI3) [-0.02, 0.00] (61-1, split due to 
diastereotopicity, Si CH3's), 0.75 - 0.84 (6H, overlapping pair of doublets, 6-CH3's), 0.91 (9H,s,t-
butyl), 0.93 (31-1, overlapping doublet, 4-CH3), 1.62 (3H,s,2-CH3), 1.66 - 1.78 (1H,m,6-H), 2.42 - 
2.65 (1H,m,4-H), 3.28 (1H, overlapping d of d, J = 6.1, 6.1 Hz, 5-H), 3.50 (IH, br s, OH), 5.47 (11-1, 
d, J=10.0 Hz, 3-H); SC/ppm  (50MHz, CDCI3) -4.01 (SiCH3's), 13.61, 18.12, 18.51, 19.74 (6-CH3S, 
4-CH3 and 2-CH3), 25.96 (t-butyl CH3's), 32.17 (6-C), 35.79 (4-C), 68.85 (CH2), 77.01 (t-butyl 
quat.C.), 80.83 (5-C), 129.48, 132.98 (2-C, 3-C); m/z (FAB) 287, 269, 251, 225, 207, 187, 165 and 
137. 
(2E:4R.5S)-5-(tert-Butyldimcthylsilylpxy)-2.4 .6-trimcthvlhept-2-enal 11791 
(2E;4R,5S)-5-(ter:-Butyldimethylsilyloxy)-2,4,6-trimethylhept-2-en-1-ol (888 mg, 3.1 mmol) was 
dissolved in dry dichloromethane (20 ml) containing powdered 4A molecular sieves (500 mg). N- 
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Methylmorpholine N-oxide (545 mg, 4.65 mmol) and tetra-n-propylammonium per-ruthenate (5.4 
mg, 15.5 M.mol) were then added to the solution and the resulting dark green reaction mixture was 
stirred at room temperature under a nitrogen atmosphere for 5 hours. The mixture was diluted with 
dichloromethane (50 ml) then washed with aqueous sodium sulphite (50 ml), brine (50 ml) and 
aqueous copper sulphate (50 ml) before being dried (MgSO4). Removal of the solvent in vacuo 
gave 799 mg of a green oil which was purified by dry-flash chromatography (Si02) petrol - 20% 
ether-petrol, gradient) to give the title compound as a clear colourless oil (620 mg, 2.2 mmol, 71%), 
t.l.c. (E) Rf = 0.30; (Found: MH, 285.20857. CaIc. for C16H3302Si: MH, 285.20858); ? max 
(CH3CN) 233 nm (e 10000); v max (CH2C12) 2960, 2700 (CH), 1680 (C=0), 1460, 1050 and 840 
cm; oH/ppm  (200MHz, CDCI3) [-0.03, 0.04] (6H, split due to diastereotopicity, Si CH3's), 0.72 - 
0.91 (15H, overlapping in, 6-CH3's and t-butyl), 0.94 - 1.05 (3H,d,J=7.5 Hz, 4-CH3), 1.10 - 1.32 
(1H,m,6-H), 1.72 (3H,d, J=1.0 Hz, 2-CH3), 2.66 - 2.98 (1H,m,4-H), 3.32 - 3.48 (IH,d of d, J=6.0, 
6.0 Hz, 5-11), 6.53 - 6.71 (1H,d of d, J=1.0, 10.0 Hz, 3-H), 9.35 (1H,s,CHO); m/z (FAB) 285, 269, 
242, 214, 187, 137 and 115. 
Ethyl (2E.4E:6R.7S)-7-(tert-butyldimethvlsilyloxy)-4.6.8-trimethvinona-2.4-dienoate 11801 
(2E;4R,5S)-5-(tert-Butyldimethylsilyloxy)-2,4,6-trimethylhept-2-enal (620 mg, 2.2 mmol) was 
dissolved in dry benzene (25 ml) then carboethoxymethylidinetriphenyiphosphorane (1.150 g, 3.3 
mmol) was added and the colourless solution heated under gentle reflux in a nitrogen atmosphere 
for 5 days. The solvent was removed in vacuo and the residual sludge purified by dry-flash 
chromatography (SiO2/petrol - 15% ether-petrol, gradient) to give a clear colourless oil (733 mg, 
2.1 mmol, 95%). The mixture of 2E and 2Z isomers was dissolved in dry dichioromethane (20 ml) 
and iodine (5 mg) was added to the stirred solution. The purple solution was irradiated with a 
500W tungsten lamp for 4 hours then washed with saturated aqueous sodium thiosuiphate ( 2 x 20 
ml), water (20 ml) and brine (20 ml) before being dried (MgSO4). The solvent was removed in 
vacuo to give the isomerically pure diene (739 mg) which was purified in the same manner as 
before so that the title compound was obtained as a clear colourless oil (730 mg, 2.06 mmol, 94%), 
t.l.c. (F) Rf = 0.31; [a]20 = + 1.80 (c=1.21, CHCI3); (Found: MH, 355.26685. Cale. for 
C20H3903Si: M1-1, 355.26683); ?. max (CH3CN) 268 nm (e 26200); v max (CH2C12) 3030 
El 
(alkene CH), 2980 (CH), 1720 (C=O), 1640 (C=C), 1460, 1150 and 840cm4; H/ppm (200MHz, 
CDC13) [0.02, 0.041 (6H, split due to diastereotopicity, Si CH31s), 0.80 - 0.91 (15H, overlapping m, 
8-CH3's and t-butyl), 0.96 - 0.99 (3H,d,J=5.0 Hz, 6-CH3), 1.29 (311,t, J=7.1 Hz, ester CH3), 1.65 - 
1.71 (1H,m,8-H), 1.76 (3H,s,4-CH3), 2.62-2.75 (IH,m,6-H), 3.34 (1H,d of d,J=5.0, 5.0 Hz, 7-H), 
4.15 - 4.26 (2H,q,J=7.1 Hz, ester CH2), 5.72 (1H,d,J=15.5 Hz, 3-H), 6.00 (1H,d,J=10.0 Hz, 5-11), 
7.34 (1H,d,J=15.5 Hz, 2-H); sc/ppm  (50MHz, CDC13) -3.93 (Si CH3ts), 12.89 (4-CH3), 13.52, 
13.92, 18.31, 19.22 (6-CH3, 8-CH3's and ester CH3), 25.88 (t-butyl CH31s), 32.86 (8-C), 36.53 (6-
C), 60.15 (ester CH2), 78.01 (t-butyl quat.C), 81.21 (7-C), 115.95, 145.87 (3-C, 5-C), 130.78 (4-C), 
151.06 (2-C), 194.92 (C=O); m/z (FAB) 355,340, 326, 310,298,253,215, 187, and 115. 
(2E.4E:6R.7S)-7-(rert-Butyldimhylsilylpxy)-4.6.8-trimethyInpnp-2.4-din-1-pl [1811 
A solution of ethyl (2E,4E;6R,7S)-7-(tert-butyldimethylsilyloxy)-4,6,8-trimethylnona-2,4-dienoate 
(700 mg, 2.0 mmol) in dry dichioromethane (40 ml) was cooled to -78 °C (dry ice/acetone) under 
argon. Diisobutylaluminium hydride (1.OM in dichloromethane; 5.0 ml, 5.0 mmol) was added and 
the mixture stirred at -78 °C for 3 hours then quenched by the careful addition of water (15 ml) 
before being warmed to room temperature over 30 minutes. The two-phase mixture was transferred 
to a separatory funnel containing dichioromethane (200 ml) and saturated aqueous sodium 
potassium tartrate (200m1), shaken and separated. The aqueous layer was extracted with 
dichioromethane (4 x lOOml) and the combined organic liquors were dried (MgSO4) and 
concentrated in vacuo to leave a pale yellow liquid. This was purified by dry-flash chromatography 
(Si02/30% ether-petrol) to give the title compound as a clear colourless oil (602 mg, 1.9 mmol, 
95%), t.l.c. (B) Rf = 0.35; [a]20 = +1.170 (c=0.99, CHC13); (Found: MlT1, 313.25628. Cale. for 
C18H3702Si: MH, 313.25627); X max (CH3CN) 236 nm (c 21000); v max (CH2Cl2) 3320 br 
(OH), 2960, 2860 (CH), 1645 (C=C), 1255 and 770 cm* 511/ppm (200MHz, CDC13)  [0.02, 0.03] 
(6H, split due to diastercotopicity, SiCH3's), 0.81 - 0.90 (15H, overlapping m, 8-CH3's and t-butyl 
CH3'); 0.93 - 0.97 (3H,d,J=7.0 Hz, 6-CH3), 1.65 - 1.77 (1H,m,8-H), 1.74 (3H,s,4-CH3), 2.61 - 2.74 
(1H,m,6-H), 3.30- 3.35 (1H,d ofd, J=5.1, 5.1 Hz, 7-H), 4.17 -4.21 (2H,d ofd, J=1.1, 6.1 Hz, CH2), 
5.55 - 5.60 (1H,d,J=10.0 Hz,5-H), 5.66 - 5.77 (IH,d oft, J=6.1, 15.0 Hz, 2-H), 6.22 - 6.29 
(1H,d,J=15.0 Hz, 3-H); SC/ppm (50MHz, CDC13) -3.91 (SiCH31S), 12.44 (4-CH3), 18.71, 19.48, 
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20.63 (8-CH3's and 6-CH3), 26.12 (t-butyl CH3ts), 32.47 (8-C), 35.98 (6-C), 68.74 (CH2), 80.77 (7- 
C), 124.71 (5-C), 132.96 (4-C), 136.62 (2-C), 137.35 (3-C); m/z (FAB) 313, 311, 269, 235, 215,201 
and 115. 
(2E.4E:6R.7S)-7-(tert-Butvldimethvlsilvloxv-4.6.8-trimethvinona-2.4-dienal [1821 
(2E,4E;6R,7S)-7-(tert-Butyldimethylsilyloxy-4,6,8-trimethylnona-2,4-dien-1-ol (582 mg, 1.86 
mmol) was dissolved in dry dichloromethane (20 ml) containing powdered 4A molecular sieves 
(400mg). N-Methylmorpholine N-oxide (328 mg, 2.8 mmol) and tetra-n-propylammonium per-
ruthenate (3.4 mg, 9.3 j.tniol) were added and the green mixture was stirred under nitrogen for 24 
hours at room temperature. The mixture was diluted with dichloromethane (30 ml) then washed 
with aqueous sodium sulphite (50 ml), water (50 ml) and aqueous copper sulphate (50 ml) before the 
organic liquors were dried (MgSO4). The solvent was removed in vacuo and the brown residue 
purified by dry-flash chromatography (Si02/petrol) to give the title compound as a clear colourless 
oil (374.4 mg, 1.21 mmol, 65%), L1.c. (E) Rf = 0.30; [a]20 = +4.60 (c=0.85, CHC13); (Found: 
MF1, 3.11.24064. Caic. for C18H3502Si: MH, 311.24062); ? max (CH3CN) 279 nm (e 24500); 
v max (CH2C12) 2960, 2850 (CH), 1670 (C=O), 1615 (C=C), 1120 and 835 cm4;5H/PPM 
(200MHz, CDC13) [0.03, 0.05] (6H, split due to diastereotopicity, SiCH31S), 0.81 - 0.90 (15H, 
overlapping M, 8-CH3s and t-butyl CH3s), 0.99 (3H,d,J=7.OHz, 6-CH3), 1.68 - 1.74 (1H,m,8-H), 
1.80 (3H,s,4-CH3), 2.72 -2.79 (1H,m,6-H), 3.36 - 3.41 (1H, overlapping d of d, J=5.1, 5.1 Hz, 7-H), 
6.02 -6.12 (1H, d of d, J=7.8, 15.6 Hz, 2-H), 6.13 (IH,d, J=10.3Hz, 5-H), 7.10 (1H,d,J=15.6 Hz, 3-
H), 9.55 (1H,d,J=7.8 Hz, CHO); m/z (FAB) 311, 309, 295, 253, 239, 215, 201 and 115. 
Attempted preparation of cinnamaldehyde [1761 
METHOD A 
A solution of ethyl cinnamate (8.811 g, 50 mmol) in dry dichloromethane (50 ml) was stirred under 
argon and cooled either to -95 °C (liq. nitrogen-acetone) or -40 °C (dry ice-CH3CN) then 
diisobutylaluminium hydride (1.OM in dichloromethane; 50 ml, 50 mmol) was added (double-ended 
needle) followed immediately by trimethylsilyl chloride (6.35 ml, 5.43 g, 50 mmol). The reaction 
mixture became yellow and was stirred at the chosen temperature for 3 hours before being quenched 
by the careful addition of aqueous hydrochloric acid (2M; 25m1) over 30 minutes then allowed to 
warm to room temperature. The layers were separated, the aqueous layer was extracted with 
dichloromethane (50 ml), and the combined organic liquors dried (MgSO4). Removal of the solvent 
in vacuo gave 8.921 g of a pale yellow liquid. Examination of the crude product showed that it was 
mainly unreacted ester containing cinnamyl alcohol [177] in a 2:1 ratio as estimated by 1H n.m.r. A 
trace of the aldehyde was observed on t.l.c. (C) Rf = 0.15 (CH20H), 0.75 (ester) and 0.90 (CHO); v 
max (neat) 3500 br (011), 3035 (aromatic Cl-I), 2980, 2840 (CH), 1715 (C=O), 1640 (C=C), 1580 
(aromatic C=C), 1450 and 770 cm'; H/ppm  (80MHz, CDCI3) 1.33 (3H,t,J=7.1 Hz, ester CH3), 
1.65 (0.5H, br s, OH), 4.13-4.39 (3H, overlapping in and q, J=7.1 Hz, ester CH2 and CH20H), 6.29 
- 6.51 (2H, overlapping in and d, J=16.0 Hz, ester (-CH and CHs of alcohol), 7.19 - 7.55 (7.5 
H,m,aromatic CHs), 7.62 (IH,d,J=16.0 Hz, -CH of ester); m/z (FAB) 177 (MH, ester), 133 
(MH, CHO), 117 (MH -H20, alcohol), 103 and 74. 
METHOD B 
Essentially the same procedure as for Method A was used except that 1,1,1-3,3,3-
hexamethy1disilazane (8.07 g, 50 mmol) was used instead of trimet.hylsilyl chloride and, after 
quenching with aqueous hydrochloric acid, the reaction mixture was shaken with saturated aqueous 
sodium potassium tartrate (100 ml). Again, a pale yellow liquid was obtained (8.781 g) which 
proved to be identical to the product described in Method A. 
2.2-Dimethyl- I .3-diox-5-en-4-one-6-methylenetriphenylphosphonium bromide 11941 
A mixture of freshly distilled 2,2,6-trimethyl-,1,3-diox-5-en-4-one (59.00 g, 415 mmol), N-
bromosuccinimide (76.54 g, 430 mmol) and benzoyl peroxide (121 mg, 0.5 mmol) in dry carbon 
tetrachloride (500 ml) was heated under reflux then irradiated with a 500W tungsten lamp for 4 
hours. The light was removed and the mixture cooled to 0 °C and the floating white solids were 
removed by filtration of the mixture through a 1 cm pad of silica. The silica pad was washed with 
carbon tetrachloride (100 ml) and the combined filtrate and washings were concentrated in vacuo to 
give 6-bromomethyl-2.2-dimethyl- 1.3-diox-5-en-4-one 11931 as a yellow lachrymatory liquid (83.46 
g, 378 mmol, 91%). 
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The crude bromide was dissolved in dry toluene (600 ml) and a solution of triphenylphosphme 
(104.92 g, 0.4 mol) in dry toluene (400 ml) was added dropwise over 45 minutes. The mixture was 
stirred for 12 hours and the precipitate was collected by filtration. Reprecipitation from solution in 
dichioromethane with ethyl acetate gave the title compound as a white solid (121.38 g, 252 mmol, 
65%), m.p. 200 °C (dec); (Found: MI of cation, 403.44202. Caic. for C25H2403P: M, 
403.44203); (Found: C,61.9%; H, 4.8%. C25H24BrO3P requires C,62.1%; H,5.0%); ?. max 
(CH3CN) 252 nm (c 10700), 342 nm (s 3300); v max (CH202) 3050 (aromatic CH), 2980 (CH), 
1735 (C=O), 1640 (C=C), 1595 (aromatic C=C),1205 and 1115 cm-1; H/ppm  (80MHz, CDCI3) 
1.35 (6H,s,2-CH3ts), 5.46 (2H,dJ=15.6 Hz, 6-CH2), 6.03 (1H,s,5-H), 7.61 - 8.06 (15H,m,aromatic 
CH's); m/z (FAB) 403, 345, 319, 303, 275, 262, 183 and 152. 
2.2-Dimethyl- 1 .3-dipx-5-en-4-one-6-methvlidenetriphenylphosphorane [1951 
The phosphonium salt (30.00 g, 62 mmol) was added to a solution of potassium carbonate (9.40 g, 
68 mmol) in water (160 ml) and the suspension was shaken for 22 hours at room temperature. The 
white solids were collected by filtration and dried in vacuo at 40 °C then reprecipitated from 
solution in chloroform with ether to afford the title compound as yellow-green crystals (15.836 g, 39 
mmol, 63%), m.p. 138-140 °C; (Found:) MH, 403.14633. Caic. for C25H2403P: rvrH, 
403.14630); ? max (CH3CN) 340 nm (c 18200); v max (CH2C12) 3040 (aromatic CH), 2960 (CH), 
1730 (C=0), 1660 (C=C), 1595 (aromatic C=C), 1100 and 920 cm1, H/ppm  (80MHz, CDC13) 
1.15 (6H, br s, 2-CH3's), 4.62 (1H,br s,5-H), 7.24 - 7.76 (16H,m,6-CH and aromatic CH's); SC/ppm 
(50MHz, CDCI3) 24.52 (2-CH3's), 103.06 (2-C), 125.82, 127.67 (5-C and 6-C), 128.74, 128.97, 
132.02, 132.86 (aromatic CH's and quat. C's), 163.36 (CH=P), 171.29 (C=0); op/ppm (36MHz, 
CDCI3) 15.21; m/z (FAB) 403, 345, 303, 275, 262, 183 and 108. 
6-Chloromethyl-2.2-dimethyl- 1.3-diox-5-en-4-one 11921 
This was prepared according to the method of Boeckmann Jr. et alia 89•  Thus the required 
compound was obtained as a yellow liquid (9.92 g, 56 mmol, 51%), t.l.c. (H) Rf = 0.17; (Found: 
MH, 177.03184. CaIc. for C71-1935C1 03: MH, 177.03184); ? max (CH3CN) 249 nm (c 8500); v 
max (CH2Cl2) 3020 (alkene CH), 2980 (CH), 1740 (C=0), 1645 (C=C), 1390 and 1020 cm'; 
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oH/ppm (200MHz, CDC13) 1.66 (6H,s,2-CH31s), 3.99 (2H,d,J=0.7 Hz, CH2), 5.50 (1H,t,J0.7 Hz,5-
H); Oc/ppm  (50MHz, CDC13) 24.63 (2-CH31s), 40.84 (CH2), 95.42 (5-C), 107.39 (2-C), 160.26 (6- 
C), 164.41 (C=O); m/z (FAB) 177, 142, 121, 75 and 62. 
6-Diethylphosphpnomethvl-2.2-dimethyl- 1.3 -dipx-5-en-4-one [1{H11 
This was prepared according to the procedure of Boeckmann Jr. et alia 89  Thus the required 
compound was obtained as a pale yellow oil (2.78 g, 10.0 mmol, 19%), t.l.c. (I) Rf = 0.16; (Found: 
MH, 279.09974. CaIc. for Cl 1H2006P: MH, 279.09974); ? max (CH3CN) 249 nm (c 6400); v 
max (CH2Cl2) 2960 (CH), 1725 (C=O), 1630 (C=C), 1370, 1270 and 900 cm; OH/ppm  (200MHz, 
CDC13, inter alia) 1.37 (6H,t,J=7.5 Hz, phosphonate CH3's), 1.61 (6H,s,2-CH3'S), 2.70 
(2H,d,J=22.0 Hz, CH2), 3.98 - 4.13 (4H,2 x quartets, overlapping, phosphonate CH2's), 5.29 
(1H,s,5-H); Oc/ppm  (50MIHz, CDC13)  16.12(phosphonate CH3s), 24.65 (2-CH3's), 33.43 (6-CH2), 
64.42 (phosphonate CH21s), 95.93 (5-C), 106.82 (2-C), 160.25 (6-C), 162.87 (C=O); Op/ppm 
(36MHz, CDC13) 20.73; m/z (FAB) 279, 261, 221, 193, 179, 169 and 123. 
Attempted preparations of 2.2-dimethvl-6-(12enta-1 '.3 '-dienyfl- 1 .3-diox-5-en-4-one 11971 
METHOD A 
The phosphorane [195] (402 mg, 1 mmol) was added to a solution of (E)-but-2-enal (92.7 pL, 70.0 
mg, 1 mmol) in the appropriate solvent (15 ml) and the mixture was stirred at room temperature 
under nitrogen until no aldehyde was seen on t.l.c. [(B), Rf = 0.8; reaction times varied from 1 to 6 
days]. The solvent was removed in vacuo and the yellow residue purified by flash column 
chromatography (Si02/50% ether-petrol) to give the title compound as a pale yellow liquid. The 
reaction was carried out in the following solvents: toluene (no reaction occurred); acetonitrile (9.7 
mg, 0.05 mmol, 5%); dichloromethane (15.5 mg, 0.08 mmol, 8%); benzene (37.0 mg, 0.19 mmol, 
19%); dimethyulphoxide (23.3 mg, 0.12 mmol, 12%): the product was obtained as a 1:1 mixture of 
I'E and 1'Z isomers. The remainder of the mass from each reaction was obtained as a yellow solid 
by flushing the column with acetone. These solids could not be identified and showed a very broad 
u.v. absorbence; t.l.c. (B) Rf= 0.4 and 0.5; (Found: MH, 195.24038. CaIc. for C11H1503: MH, 
195.24040); ?.. max (CH3CN) 225 nm (c 4400), 303 nm (c 15600); v max (CH2C12) 3030 (alkene 
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CH), 2970 (CH), 1735 (C=O), 1640 (C=C), 1385 and 1020 cm-1; H/ppm  (80MHz, CDC13) 1.67 
(6H,s,2-CH3's), 1.82 (3H,d,4'-CH3, J=5.0 Hz), 5.24 (1H,s,5-H), 5.74 - 6.17 (3H,m,alkene CH's), 
6.72 - 6.91 (1H,m,alkene CH); m/z (FAB) 195, 149, 139, 122 and 96. 
METHOD B 
The phosphorane [195] (402 mg, 1 mmol) was added to a solution of (E)-but-2-enal (82.7 jIL, 70.0 
mg, 1 mmol) in the appropriate solvent (15 ml) and the mixture was heated to 40 °C in a 
thermostated oil-bath (under an atmosphere of nitrogen) for 3 days. The mixture was cooled to 
room temperature and the solvent removed in vacuo to give a solid yellow residue which was 
purified by flash column chromatography (Si02/50% ether-petrol) to give a 1:1 mixture of the 1'E 
isomer of the title compound and another product which appeared to have arisen from cycisation of 
the l'Z isomer. The reaction was carried out in the following solvents: dichloromethane (15.5 mg, 
0.08 mmol, 8% of desired product and 15,0 mg, 0.08 mmol, 8% of cyclised product); acetonitrile 
(21.4 mg, 0.11 mmol, 11% and 17.5 mg, 0.09 mmol, 9%); dimethy)ulphoxide (23.3 mg, 0.12 
mmol, 12% and 19.4 mg, 0.1 mmol, 10%); benzene (23.3 mg, 0.12 mmol, 12% and 17.5 mg, 0.09 
mmol, 9%). Near quantitative mass recovery was achieved on flushing the column with acetone: 
this gave a yellow solid material similar to that obtained in method A. The desired product which 
on t.l.c. (B) had Rf = 0.5 gave identical spectral data to that reported previously. The data for the 
cydised product [2001 were as follows: t.l.c. (B) Rf = 0.35; (Found: MR, 195.24039. Calc. for 
C1 1H1503: MH, 195.24040); X max 223 nm (€ 9800), 282nm (c 2100), 310 nm (e 2500); v max 
(CH2C12) 3040 (alkene CH), 2980 (CH), 1740 (C=O), 1640 (C=C), 1390 and 1020cm4; H/ppm 
(60MBz, CDC13) 1.0 - 1.3 (9H,m,2-CH3's and 4'-CH3), 2.0 (2H,m,1'-CH2), 2.4 (1H,m,4'-H), 5.7 - 
6.6(2H,m,2'-Hand3'-H);m/z(FAB) 195, 136, 121,108 and 68. 
Pent-4-enpl 12021 
A solution of pent-4-en-1-ol (10.35 g, 120 mmol) in dry dichloromethane (60 ml) was added rapidly 
to a vigorously stirred slurry of pyridinium chlorochromate (38.80 g, 180 mmol) in dry 
dichloromethane (360 ml) and the reaction was stirred for 18 hours. Ether (500 ml) was added and 
the supernatant liquid decanted off. The black residual tar was triturated with ether (2 x 500 ml) 
until it became a granular solid and the combined organic liquors were filtered through a 2 cm silica 
pad then concentrated in vacuo to give a green liquid which was purified by Kugelrohr distillation 
to afford the title compound as a colourless liquid (stench!) (5.95 g, 70.8 mmol, 59%), b.p. 80 °C/45 
mm Hg; t.l.c. (B) Rf = 0.9; (Found: MH, 85.12586. Caic. for C5H90: MH, 85.12688); v max 
(neat) 3090 (alkene CH), 2960 (CH), 2830, 2730 (CR0), 1730 (C=0), 1650 (C=C) and 920cm; 
H/PPm (60MHz, CDC13) 2.3 - 2.6 (4H,m,2-CH2 and 3-CH2), 4.9 - 5.3 (2H,m,5-CH2), 5.7 - 6.1 
(1H,m,4-H), 9.9 (1H,t,J=2.0 Hz, CHO); m/z (FAB) 85 and 57. 
2.2-Dimethyl-6-(hexa-1 '.5'-dienvl)- 1 .3-diox-5-en-4-one F2031 
2,2-Dimethyl-1,3-diox-5-en-4-one-6-methylidenetriphenylphosphorane (804 mg, 2 mmol) was 
added to a solution of pent-4-enal (168 mg, 2 mmol) in dry benzene (20 ml) and the mixture was 
heated to 40 °C in a thermostated oil-bath (under an argon atmosphere) for 22 hours. Analysis of 
the reaction mixture by t.l.c. (B) showed baseline material plus two spots Rf = 0.4 and 0.6. The 
reaction mixture was irradiated with a 500W tungsten lamp for 4 hours after which only the baseline 
and Rf = 0.4 spots were seen. The solvent was removed in vacuo and the yellow solid residue was 
purified by flash column chromatography (Si02/50% ether-petrol) to give the title compound as a 
pale yellow liquid (87.5 mg, 0.42 mmol, 21%). Again, when the column was flushed with acetone, 
near quantitative mass recovery of a yellow solid with a very broad u.v. absorbance was achieved; 
t.l.c. (B) Rf = 0.4; (Found: NMI, 209.26747. Calc. for C12H1703: NMI, 209.26749); 2. max 
(CH3CN) 230 nm (e 4100), 279nm (c 11400); v max (CH2C12) 3035 (alkene CM, 2980 (CH), 1740 
(C=O), 1635 (C=C), 1390 and 1025 cm-1; H/ppm  (200MHz, CDC13) 1.69 (6H,s,2-CH3'S), 2.14 - 
2.33 (4H,m,3'- and 4'-CH2's), 4.95 - 5.07 (2H,m,6'-CH2), 5.23 (1H,s,5-H), 5.69 - 5.94 (2H, 
overlapping m and d, J=15.0 Hz, 5'-H and 1'-H), 6.46 - 6.61 (1H,dt,J=7.5,15.0 Hz, 2-H); sc/ppm 
(50MHz, CDC13)  16.05 (2-CH3's), 31.84, 32.20 (3'- and 4'-CH2s), 93.32 (5-C), 106.14 (2-C). 
115.44 (6'-CI-12), 122.77, 136.92, 141.33 (1-,2'- and 5'-CH's), 161.86 (6-C), 163.13 (C=0); m/z 
(FAB) 209,201, 185, 168, 151 and 139. 
Attempted preparation of (±)-6-(pent-3-en-2-oIyl)-2.2-di meth vl- 1.3 -d iox-5-en-4-one 	12061 
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METHOD A 
A solution of diisopropylamine (3.67 g, 36.3 mmol) in anhydrous tetrahydrofuran (25 ml) was 
cooled to 0 °C (ice bath) under argon and n-butyllithiuni (1.6M in hexanes; 22 ml, 34 mmol) was 
added and the mixture stirred for 30 minutes. The mixture was cooled to -78 °C (dry ice/acetone) 
then a solution of 2,2,6-trimethyl-1,3-diox-5-en-4-one (3.55 g, 25 mmol) in anhydrous 
tetrahydrofuran (10 ml) was added (double-ended needle) and the mixture stirred until a white 
precipitate had formed. Distilled trimethylsilyl chloride (3.26 g, 30 mmol) in anhydrous 
tetrahydrofuran (10 ml) was added via syringe and the precipitate disappeared as the siiyijenoi 
ether formed. After 15 minutes a solution of (E)-but-2-enal (1.756 g, 25 mmol) in anhydrous 
tetrahydrofuran (15 ml) was introduced followed immediately by anhydrous tin tetrachloride (0.3 
ml, 651 mg, 2.5 mmol) and the reaction was stirred at -78 °C for 3 hours before being quenched by 
the addition of aqueous HCl (2M;100ml). The reaction was warmed to room temperature during 30 
minutes then transferred to a separatory funnel containing ether (100 ml). The layers were 
separated, the aqueous being extracted with ether (100 ml) and the combined organic extracts were 
washed with aqueous sodium bicarbonate (80 ml), water (100 ml) and brine (100 ml) then dried 
(MgSO4) and concentrated in vacuo. The yellow residue (4.709 g) was purified by flash column 
chromatography (SiO2/ether-petrol) to give the starting material (t.l.c. (B) Rf = 0.2, 860 mg) 
followed by 6-(4'-pxo-2-methylbutyfl-2.2-dimethyl-1 .3-diox-5-en-4-one 12051 as a pale yellow 
liquid (3.767 g, 17.8 mmol, 71%), t.l.c. (B) Rf = 0.1; (Found: M1H, 213.11268. Calc. for 
C11H1704: MH, 213.11267); X max (CH3CN) 247 nm (c 9000); v max (CH2C12) 3030 (alkene 
CH), 2980 (CH), 2830, 2720 (CHO), 1725 br (C=O), 1630 (C=C), 1010 and 900 cm-1; H/ppm 
(200MHz, CDC13) 1.00 (3F1,d,J=6.0 Hz, 2'-CH3), 1.65 (6H,s,2-CH31S), 2.12 - 2.46 (5H,m,1- and 2'-
CH2's plus 2'-}i), 5.20 (1H,s,5-H), 9.75 (1H,t,J=2.0 Hz,CHO); SC/ppm  (50MHz, CDC13) 19.46 (2-
CH3's), 24.69, 25.39 (2'-C and 2'-CH3), 40.18, 49.76 (1'- and 3'-CH2's), 94.40 (5-C), 106.22 (2-C), 
160.69 (6-C), 169.54 (C=O), 200.74 (aldehyde C=O); m/z (FAB) 213, 195, 155, 147, 137 and 113. 
METHOD B 
WV 
The procedure was the same as for method A except zinc (II) iodide (798mg, 2.5mmol) in 
anhydrous tetrahydrofuran (5m1) was added instead of tin tetrachloride. Thus, starting material 
(884mg) and 6-(4'-oxo-2'-methvlbutvl)-2.2-dimethvl-1 .3-diox-5-en-4-one [2051 (3.650 g, 17.2 
mmol,69%) were obtained and gave identical spectral data to that reported above. 
Methyl.4-bromo-3-oxobutyrate [2101 
This was prepared exactly according to the procedure of Duthailer127. Thus, the required 
compound was obtained as a clear colourless liquid (67.28 g, 345 mmol, 69%), b.p. 60 °C/0.3 mm 
Hg (lit.127 b.p. 57 °C/0.1 mm Hg); (Found: MB, 194.96571. Caic. for C5H7Br 03: MFI, 194.9 
6573); v max (neat) 2960 (CH), 1735 (C=0), 1660, 1630 (enol form C=O and C=C), 1440 and 1010 
cm- ; H/ppm (80MHz, CDC13) 3.61 (2H,s,2-CH2), 3.71 (3H,s,-OCH3), 3.96 (2H,s,4-CH2); also 
present were signals due to the enolic form (circa 16%) 3.74 (s,OCH3), 3.83 (s,4-CH2), 5.23 (s,2-
CH), 11.87 (brs,OH); sc/ppm (90MHz, CDC13) 33.70 (C-2), 45.53 (C-4), 52.31 (CH3), 166.76 (C- 
1), 194.16 (C-3); m/z (FAB) 194, 163 and 115. 
Ethyl 4-bromo-3-oxobutvrate 12051 
This was prepared by using the procedure reported by Duthailer127. Thus, the title compound was 
obtained as a clear colourless liquid (72.31 g, 346 mmol, 69%), b.p. 68 °C/1.0 mm Hg; (Found: 
MH, 210.05378. CaIc. for C6FI10Br 03: MIH, 210.05380); v max (neat) 2980 (CH), 1735 br 
(0=0), 1655, 1635 (enol form C=0 and C=C), 1450 and 1030 cm-1; 	/ppm (80MHz, CDC13) 
1.24 (3H,t,J=7.0Hz,CH3), 3.65 (2H,s,2-CH2), 4.01 (2H,s,2-CH2), 4.12 (2H,q,J7.0 Hz, ester CH2); 
also present were signals due the to enolic form (circa 30%) 3.81 (s,4-CH2), 5.24 (s,2-CH), 11.85 
(br s, OH); m/z (FAB) 210, 181, 165, 131 and 117. 
Methyl 4-(dimethylphosphono)-3-oxobutyrate 12111 
The procedure published by Bodalski et alia 126  was employed in an attempt to prepare the title 
compound. Unfortunately, none of the desired phosphonate could be isolated from the crude 
product as it decomposed on distillation. Analysis of the crude product showed hp/ppm (36M}lz, 
CDC13) 19.62 consistent with a phosphonate species. 
Ethyl 4-(diethylphosphono)-3-oxobutvrate [21)91 
The procedure of Bodalski et alia 126  was followed in an attempt to prepare the required 
compound. The crude product showed p/ppm (36MHz, CDC13) 18.98, [lit.126 Ippm (CHC13) = 
18.96; b.p. 120 °C/0.4 mm Hg] consistent with the presence of a phosphonate species, but the 
material decomposed on distillation leaving an intractable black tar. 
Methyl (4E.6E)-3-oxo-octa-4 .6-dienoate [2121 
A solution of the crude methyl 4-(dimethylphosphono)-3-oxobutyrate (2.02 g, circa 9 mmol) in 
anhydrous tetrahydrofuran (10 ml) was added slowly to a slurry of sodium hydride (50% w/w in oil; 
864 mg, 18 mmol) in anhydrous tetrahydrofuran (20 ml) and the mixture was stirred under argon 
until no more hydrogen gas was evolved (circa 30 minutes). (E)-But-4-enal (631 mg, 9 mmol) in 
anhydrous tetrahydrofuran (5 ml) was added to the brick-red solution and the mixture was stirred at 
room temperature for 18 hours. The reaction mixture was poured carefully on to brine (100 ml) then 
aqueous hydrochloric acid (2M; lOmI) was added and the aqueous mixture extracted with ether (4 x 
50 ml). The combined extracts were dried (MgSO4) and the solvent removed in vacuo to leave an 
orange-yellow sludge (1.43 g) which was purified by flash-column chromatography to give the title 
compound as a yellow semi-solid (381 mg, 2.3 mmol, 25%), t.l.c. (C) Rf = 0.50; (Found: MH, 
169.202 15. Calc. for C91-11303: MH, 169.20216); ?. ma (CH3CN) 276 nm (c 8900), 340 nm (F-
5400), 
c
(CH3CN + 1 drop NaOH) 244nm (c 8400), 340 nm (r 9250); v max (CH2C12) 2980 (CH), 
1745 (C=O), 1665, 1630 (C=O and C=C of enol), 1420 and 1230 cm* /ppm (200MHz, CDC13) 
0.99 (3H,d,J=7.5 Hz, 7-CH3), 3.16 (2H,s,CH2), 3.71 (3H,s,OCH3), 5.95 - 6.29 (3H,m,5-,6- and 7-
H's), 7.00 - 7.25 (1H,m,4-H); also present were signals due to the enolic form [213] (circa 22%) 
3.77 (s,OCH3), 5.02 (s,CH), 12.16 (s,OH); m/z (FAB) 169, 141, 138, 128 and 125. 
(5S)-5-[2 (Hvdroxvcarbonvl)ethvll -1 -methyl-3-(3"-oxobutanoyl)tetramic acid 11B31 
(5S)-5-[2'-(ierz-Butyloxycarbonyl)ethyl]- 1 -methyl-3-[5"-(3'-methylisoxazolyl)]tetramic  acid (62.5 
mg, 0.19 mmol) was dissolved in aqueous sodium hydroxide (0.4M; 12m1) then 10% palladium on 
charcoal catalyst (6.2 mg) was added and the mixture stirred under a hydrogen atmosphere at 
MI 
standard temperature and pressure for 20 hours. The catalyst was removed by filtration through a 
Celite pad, the alkaline liquors were then cooled (ice-bath) and acidified to pH 1.0 with 2M HC1(aq) 
before being extracted with ethyl acetate (2 x 50 ml). The combined extracts were dried (MgSO4) 
and concentrated in vacuo to give the title compound as a pale yellow oil (43.5 mg, 0.16 mmol, 
85%), [0t]20 = -43.70 (c=1.01, CHC13); ? max (CH3CN) 225 nm (E 7500), 282 nm (c 8700), 
(CH3CN + 1 drop 1M NaOH) 246 nm (E 11200), 284 nm (e 11800), 356 nm (c 5200); v max 
(CH2C12) 3500 br (CO214), 2960 (CH), 1740 sh, 1710 (C=O), 1650, 1630 (C=O and C=C of enol) 
and 1 150cm;H/ppm  (200MHz, CDC13) 2.04 - 2.39 (4H,m,1'- and 2'-CH21s), 2.26 (3H,s,COCH3), 
[2.99, 3.01] (3H, split due to tautomensm, NCH3), 3.89-3.99 (1H,m,5-H), 3.98 (2H,s,2"-CH2), 
10.45 (2H,br s, CO2H and enol OH); m/z (FAB) 270, 252,228 and 224. 
Silylation of (5S)-5-[2-(hydroxycarbonyl)ethyll- I -methvl-3-(3 '-oxobutanoyl)tetramic acid [131 
Triethylamine (265 jiL, 1.9mmol) was added to a solution of (5S)-5-[2'-(hydroxycarbonyl)ethyl]-1- 
methyl-3-(3'-oxobutanoyl)tetramic acid (86 mg, 0.32 mmol) in dry dimethylformamide (2.5 ml) and 
the mixture stirred under argon before trimethylsilyl chloride (143 ILL, 1.12 mmol) was introduced 
via syringe. The resulting reaction mixture was then stirred at room temperature for 16 hours. The 
solvent was removed in vacuo and the residue partitioned between ether (10 ml) and water (10 ml). 
The layers were shaken and separated, and the ethereal layer washed with water (10 ml), then dried 
(MgSO4). Concentration of the liquors in vacuo gave 10.9 mg of the crude iris (trimethylsilyl) 
derivative, ? max (CH3CN) 260 nm (c 3400), 382 nm (e 1700), X max (CH3CN + 1 drop 1M 
NaOH) 265 nm (e 3400), 354 nm (e 12900). 
Attempted 	preparations 	of 	(5S)-5-12'-(tert-butyloxycarbonyl)ethyll -1 -methyl-3-[5 "-(3"- 12"- 
hydroxynent-3"-enyl ispxazolyl)ltetramic acid [2171 
(5S)-5-[2'-tert-Butyloxycarbonyl)ethyl]- 1 -methyl-3-[5"-(3"-methylisoxazolyl)]tetramic acid (29.0 
mg, 0.09 mmol) was dissolved in anhydrous tetrahydrofuran (2 ml) then cooled to -78 °C (dry 
ice/acetone) under argon. n-Butyllithium (1.3M in hexanes; 0.14 ml, 0.18 mmol) was added slowly 
(via syringe) and a yellow colour was observed immediately. A solution of crotonaldehyde (6.3 mg, 
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0.09mmol) in anhydrous tetrahydrofuran (imi) was introduced using a syringe causing the reaction 
mixture to turn pale yellow. The reaction was stirred at -78 °C for 4 hours then allowed to attain 
room temperature over a period of 30 minutes. The solvents were then removed by concentration in 
vacuo and the residual pale yellow solids were partitioned between ether (15 ml) and water (15 ml), 
the layers being shaken then separated. The aqueous liquors were cooled in ice and carefully 
acidified to pH 2.0 with aqueous HCl (0.7M). The cloudy acidic solution was extracted 
immediately with ethyl acetate (3 x 25 ml) and the extracts were combined before being dried 
(MgSO4). Removal of the solvent in vacuo gave a pale yellow oil (36.5 mg) which appeared to 
contain the title compound; (Found): MH, 393.20253. Calc. for C20H29N206: MH, 393.20253. 
Calc. for C20H29N206: M1F, 393.20255); X max (CH3CN) 268 nm (c 12900), 315 nm (c 17800); 
111 n.m.r. showed signals corresponding to the title compound but was too complex for full 
assignment; m/z (FAB) 393. 375, 365, 337, 319, 267, 207, 193 and 138. 
METHOD B 
Exactly the same reaction conditions and work-up were used (as those in Method A) except lithium 
diisopropylamide (2.0 equivalents; 1.5M in cyclohexane; 0.15 ml, 0.224 mmol) was employed as 
the base. This gave 52.6 mg of a yellow oil which was identical to that obtained previously, id est 
spectral evidence suggested that the desired product was present in the complex crude mixture. 
METHOD C 
The third method attempted differed from the first two in the following ways: the base employed 
was sec-butyllithium (2.0 equivalents; 1.3M in cyclohexane; 0.57 ml, 0.74 mmol) and the reaction 
was carried out at -20 °C (dry ice/carbon tetrachloride) for 4 hours. The same work-up was used 
giving 140.4 mg of a green-yellow oil; (Found: M}1, 393.20257. Calc. for C20H29N206: MH, 
393.20255); other spectral data was similar to the earlier attempts. 
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(5S)-5-[2'-(teri-Butvloxvcarbonvl)ethvll-1-methvl-345"43"- (2'"-oxo-4"-phenvlbut-3"'-enyll - 
isoxazolyl')ltetramic acid 	C2201 
Essentially the same procedure was followed as for method C (preceding experiment) except that 
ethyl cinnamate (1.0 equivalent; 71.0 mg, 0.4 mmol) was used as the electrophile and the reaction 
temperature was -78 °C (dry ice/acetone) throughout. An identical work-up of the reaction gave 
284.0 mg of a yellow-green oil. This crude product was found to be not the title compound but 
(5S)-5-[2'-(tert-butvloxvcarbonvflethvll-1 -methyl-4-O-cinnamoyl-3-[5"-(3"-methvlisoxazolyl)1- 
tetramic acid [2191; (Found: MIH, 453.20256. Caic. for C25H29N206: MH, 453.20255); X max 
(CH3CN) 273 nm(e 12200), 298 nm (e 8800); v max (CH2Cl2) 3030 (aromatic CH), 2980 (CH), 
1710 br (C=O), 1640 (C=C), 1605 (aromatic C=C), 1000, 650cm; oH/ppm (200M}Iz, CDC13) 
1.41 (9H,s,z-butyl), 2.16- 2.30 (4H,m,CH21S), 2.33 (3H,s,isoxazole CH3), 2.95 (3H,s,NCH3), 4.05 - 
4.12 (1H,m,5-H), 6.40 (1H,d,J16.0 Hz,cinnamoyl CH), 6.65 (1H,s,isoxazole CH), 7.31-7.38 
(3H,m,aromatic Hb  and  He),  7.41 - 7.52 (2H,m,aroniatic Ha),  7.63 (1H,d,J=15.OHz, cinnamoyl CH); 
m/z (FAB) 453, 425, 395, 379, 347, 321, 283, 264, 207 and 131. 
(5S)-5-[2'-(tert-Butyloxvcarbonyl)ethvll-1 -methyl-3-[5"-(3"- 12"-hydroxypent-3-envll - 
isoxazolyl)ltetramic acid [2171 
METHOD D 
(5S)-5-[2'-(tert-Butyloxycarbonyl)ethyl] -1 -methyl-3-[5"-(3 '-methylisoxazolyl)]tetramic acid (161 
mg, 0.5 mmol) was dissolved in anhydrous tetrahydrofuran (10 ml) and the solution was cooled to - 
78 °C (dry ice/acetone) under argon. sec-Butyllithium (1.3M in cyclohexane; 0.38 ml, 0.5 mmol) 
was added and the yellow mixture stirred for 5 minutes before a solution of tert-butyldimethylsilyl 
chloride (75.4 mg, 0.5 mmol) in anhydrous tetrahydrofuran (1 ml) was introduced into the reaction 
vessel. After another 5 minute period a second equivalent of sec-butyllithium (1.3M in 
cyclohexane; 0.38m1, 0.5mmol) was added and the orange-yellow mixture stirred at -78 °C for 10 
minutes. A solution of crotonaldehyde (35.0 mg, 0.5 mmol) in anhydrous tetrahydrofuran (1 ml) 
was then added and the resulting mixture was stirred at -78 °C for 3 hours then allowed to warm to 
room temperature during 30 minutes. Removal of the solvents in vacuo gave a yellow residue 
which was paiioned between ether (30 ml) and water (30 ml). The immiscible layers were shaken 
103 
then separated. The aqueous layer was extracted with ether (2 x 15 ml) and the combined organic 
liquors were dried (MgSO4) before being evaporated under reduced pressure. The resulting green 
syrup (255.1 mg) was triturated with ether to give an unidentified white solid (100 mg, u.v. 
inactive). Concentration of the supernatant liquors in vacuo afforded a green solid-foam in which 
the title compound was present; (Found: MH, 393.20253. 	Calc. for C20H29N206: 
MH,393.20255); A. max (CH3CN) 239 nm (e 10000), 272 nm (E 8000), A. max (CH3CN + 1 drop 
1M NaOH) 271 nm (c 11000), 306nm (c 15300); H/ppm  (360MHz, CDC13, inter alia) 1.40 (9H,s,t-
butyl), 2.03 - 2.25 (4H,m,CH2's), 2.97 (3H,s,NCH3), 3.22 (2H,m,1-CH2), 4.00 - 4.07 (1H,m,5-H), 
5.42 - 5.85 (2H,m,CH=CH, 6.63 (1H,s,isoxazole CH); m/z (FAB) 393, 375, 365, 337, 319, 267, 193 
and 138. 
(5S-5-[2'-(tert-Butyloxycarbonyl)ethyl1-1 -methyl-3-[5"-(3"- Ipenta- 1".3"-dienyl) - 
isoxazplyl)ltetramic acid 
A single crystal of p-toluenesulphonic acid was added to a solution of (5S)-5-[2'-(tert- 
butyloxycarbonyl)ethylj- 1 -methyl-3-[5" -(3"- (2"'-hydroxypent-3"-enyl) isoxazolyl)]tetramic 	acid 
(13.8 mg, 35.2 jmol) in dry dichloromethane (6 ml) and the mixture was refluxed for 4 hours. The 
solution was diluted to a volume of 20 ml with dichloromethane then washed with aqueous sodium 
bicarbonate (10 ml), water (10 ml) and brine (10 ml). The organic liquor was then dried (MgSO4) 
and concentrated in vacuo to give a yellow sludge (12.5 mg) which contained the title compound; 
(Found: M1H, 375.19 198. CaIc. for C20H27N205: MH, 375.19198); A. max (CH3CN) 269 nm (F-
9500), 
s
304 nm (e 11000), 358 nm (e 3600); m/z (FAB) 375, 347, 323, 267, 217 and 149. 
Attempted 	coupling 	of 	(5S)-5-[2'-(rert-butvloxycarbonyl)ethyll- 1 -methvl-3-15"-(3 
methvlisoxazolvl1tetramic acid [1201 and (2E.4E:6R.7S)-7-(terr-butvldimethvlsilvloxv)-4.6.8-
trimethvinona-2.4-dienal [1821 
The coupling was carried out under identical conditions to those described earlier (Method D), with 
(2E,4E;6R,7S)-7-(tert-butyldimet.hylsilyloxy)-4,6,8-trimethylnona-2,4-dienal (155.3 mg, 0.5 mmol) 
being used as the electrophile. The work-up was slightly different; the reaction solvent was 
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removed in vacuo and the yellow residue partitioned between ether (30 ml) and water (30 ml). The 
layers were shaken and separated - the aqueous layer was cooled in ice and acidified to pH 1.5 with 
0.7M HC1 (a deep red colour was seen). The acidic solution was extracted immediately with ether 
(3 x 60 ml) until the colour was no longer apparent in the aqueous layer and the organic extracts 
were dried (MgSO4). The solvents were removed in vacuo giving a brown residue which was 
purified by dry-flash chromatography (Si02/50% ethycetate-hexane - ethyl acetate gradient). The 
material which had Rf = 0 (I) (74.7 mg) appeared to contain a tetramic acid - mainly starting 
material with some (3"E5"'E:5S.7"'R.8"'S)-5-12'-(tert-butvloxvcarbonvI)ethvl1-1 -methyl-3-15'-(3"-
(2"-hvdroxv-8"'-(tert-butvldimethvlsi1vloxv-5"'.7".9"'-trimethyldeca-3".5"-dienvI ' isoxa7olyl)1- 
tetramic acid [2221 being present; (Found: MH, 633.39353. Cale. for C34H57N207Si: MI1, 
633.39348); ? max (CH3CN) 272 nm (e 10900), 305 nm (c 7400), ?. max (CH3CN + 1 drop 1M 
NaOH) 272 nm (E 12600); 1H n.m.r. on the crude material indicated that the main constituents of 
the mixture were the two starting compounds; m/z (FAB) 633, 615, 560, 518, 502, 445, 429, 405, 
323, 267, 217 and 187. 
4. APPENDIX: COURSES ATTENDED 
Organic Research Seminars 1988, 1989 and 1990, (various speakers). 
Medicinal Chemistry,(Professor P.G. Sammes, Brunel University). 
Medicinal Chemistry, (Dr M. Paton, University of Edinburgh, 4th year lecture course). 
Advances in Organic Chemistry 1988, 1989 and 1990, (various lecturers, University of Edinburgh). 
Two-dimensional Nuclear Magnetic Resonance Spectroscopy, (Dr I.H. Sadler, University of 
Edinburgh). 
Industrial Processes, (various speakers, I.C.I. Grangemouth and Department of Chemical 
Engineering, University of Edinburgh). 
Scientific German: Introductory Reading and Translation, (Dr G.M. Burnett, German Department, 
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